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T-cell immunity requires extremely rapid clonal proliferation of rare,
antigen-specific T lymphocytes to form effector cells. Here we
identify a critical role for ETAA1 in this process by surveying random
germ line mutations in mice using exome sequencing and bioinfor-
matic annotation to prioritize mutations in genes of unknown
function with potential effects on the immune system, followed by
breeding to homozygosity and testing for immune system pheno-
types. Effector CD8+ and CD4+ T-cell formation following immuni-
zation, lymphocytic choriomeningitis virus (LCMV) infection, or
herpes simplex virus 1 (HSV1) infection was profoundly decreased
despite normal immune cell development in adult mice homozygous
for two different Etaa1 mutations: an exon 2 skipping allele that
deletes Gly78-Leu119, and a Cys166Stop truncating allele that elim-
inates most of the 877-aa protein. ETAA1 deficiency decreased
clonal expansion cell autonomously within the responding
T cells, causing no decrease in their division rate but increasing
TP53-induced mRNAs and phosphorylation of H2AX, a marker of
DNA replication stress induced by the ATM and ATR kinases. Ho-
mozygous ETAA1-deficient adult mice were otherwise normal,
healthy, and fertile, although slightly smaller, and homozygotes
were born at lower frequency than expected, consistent with par-
tial lethality after embryonic day 12. Taken together with recently
reported evidence in human cancer cell lines that ETAA1 activates
ATR kinase through an exon 2-encoded domain, these findings
reveal a surprisingly specific requirement for this ATR activator
in adult mice restricted to rapidly dividing effector T cells. This
specific requirement may provide new ways to suppress patholog-
ical T-cell responses in transplantation or autoimmunity.
T cell | DNA damage | replication stress | Etaa1 | immunity
Tlymphocytes play an essential role in adaptive immunityagainst pathogenic microbes and tumors. In the absence of
stimulation, peripheral T cells remain in a quiescent naïve state.
When a microbial antigen binds to the T-cell receptor on a rare
antigen-specific T-cell, the cell undergoes rapid proliferation,
clonal expansion, and effector differentiation (1, 2). Failure of
antigen-specific T cells to proliferate in response to replicating
virus, bacterium, or yeast can lead to uncontrolled fatal infection.
For this reason, T-cell proliferation in vivo in response to in-
fection is one of fastest cell proliferation rates known (3). Fast
cell division undoubtedly places enormous stress on proliferating
T cells. T cells cope with the metabolic demands of rapid growth
by undergoing a dramatic metabolic shift to a more ana-
bolic metabolic state (4); however, how T cells cope with all of
the challenges of rapid DNA replication is unclear. The stress
associated with DNA replication in proliferating T cells is
illustrated by their heightened susceptibility to the DNA
topoisomerase II inhibitor etoposide (5, 6). Identifying critical
components for T-cell replication in vivo would provide new
targets for developing immunosuppressive drugs to prevent
damaging T-cell responses in organ transplantation and autoimmune
disease.
Rapid genome replication presents unique challenges to pro-
liferating cells (7). During DNA replication, the replication ma-
chinery often encounters “roadblocks” in the form of spontaneous
DNA damage, collisions with the transcription machinery, or in-
sufficient deoxynucleotide substrates for DNA polymerase (8).
Such disruptions can interfere with DNA replication and cause
stalling or collapse of the replication fork. Replication stalling or
collapse leads to the exposure of single-stranded DNA (ssDNA)
by the continued activity of DNA helicase, and this ssDNA will be
attacked by nucleases to create double-stranded (ds) breaks in the
absence of an appropriate cellular response. Thus, cells have
evolved a replication stress response that first detects stalled
replication forks and then acts to insulate the ssDNA against
damage and to arrest cell cycle progression. The Replication
Protein A (RPA) complex binds and protects ssDNA at stalled
replication forks, and recruits a complex set of repair and restart
proteins that includes the protein kinase Ataxia Telangiectasia and
Rad3-Related (ATR). ATR elicits checkpoint signaling by phos-
phorylating BRCA1, CHEK1, MCM2, TP53, and other proteins
that inhibit DNA replication and promote DNA repair, re-
combination, and apoptosis, and also phosphorylates Ser-139 of
histone H2AX (denoted γH2AX), which serves as an experimental
Significance
T cells are required for control of many intracellular infections, and
a critical component of T cell immunity is the prolifera-
tive expansion of effector T cells upon stimulation. Using a
forward-based genetic screen, we identify the mouse Etaa1 gene
as critically important for T cell proliferative expansion after vac-
cination and during infection. Consistent with recent findings that
ETAA1 prevents DNA damage during proliferation, our data
demonstrate elevated DNA damage within Etaa1-deficient effec-
tor T cells, which likely leads to cell death. This phenotype is re-
stricted to effector T cell proliferation, with T cell development and
other immune parameters remaining normal. Thus, ETAA1 may
represent a novel drug target to selectively suppress pathological
T cell responses in transplantation or autoimmunity.
Author contributions: L.A.M., K.H., A.E., D.C.T., C.C.G., and I.A.P. designed research;
L.A.M., Y.S., A.C., K.H., T.A.R., Y.M., M.V.W., D.R.H., and I.A.P. performed research; K.H.
contributed new reagents/analytic tools; L.A.M., Y.S., A.C., K.H., T.A.R., Y.M., M.V.W.,
D.R.H., D.C.T., C.C.G., and I.A.P. analyzed data; and L.A.M., C.C.G., and I.A.P. wrote
the paper.
Reviewers: R.A., Emory University; and B.S., Cold Spring Harbor Laboratory.
The authors declare no conflict of interest.
Data deposition: RNA-seq data have been deposited in the Gene Expression Omnibus
(GEO) database, https://www.ncbi.nlm.nih.gov/geo (accession no. GSE99144).
1Present address: Department of Microbial Sciences, University of Surrey, Guildford,
United Kingdom.
2C.C.G. and I.A.P. contributed equally to this work.
3To whom correspondence may be addressed. E-mail: c.goodnow@garvan.org.au or ian.
parish@anu.edu.au.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.
1073/pnas.1705795114/-/DCSupplemental.
www.pnas.org/cgi/doi/10.1073/pnas.1705795114 PNAS Early Edition | 1 of 10
IM
M
U
N
O
LO
G
Y
A
N
D
IN
FL
A
M
M
A
TI
O
N
PN
A
S
PL
U
S
marker of DNA replication stress and damage. ATR phosphory-
lation of CHEK1 and MCM2 is stimulated by Topoisomerase II-
Binding Protein 1 (TOPBP1). A universal requirement in rapidly
dividing cells for the core components of the replication stress re-
sponse is implied by early embryonic lethality in mice homozygous
for knockout or hypomorphic mutations in Rpa1, Atr, and Topbp1
(9–13); however, whether specific components are selectively
needed to insulate proliferating effector T cells against replication
stress is unclear.
At the time that we conducted the studies described herein,
the Ewing’s tumor- associated antigen 1 (Etaa1) gene had no
known function, encoding a pioneer protein with no recognizable
domains that had been isolated by an antibody against a surface
antigen on Ewing’s tumors (14). Because Etaa1 mRNA was most
abundant in T and B lymphocytes among all mouse tissues ex-
cept embryonic stem cells (BioGPS data for probe 1453064_at;
biogps.org) (15) and encoded part of the “dark proteome,” it was
a good candidate to test for immune system phenotypes in a
systems-guided forward genetics screen. The screen starts by
exome sequence analysis to identify large numbers of heterozy-
gous de novo point mutations in the mouse genome induced at
random in first-generation (G1) offspring of inbred C57BL/6
mice treated with ethylnitrosourea (ENU) (16, 17). Computa-
tional filtering then identifies mutations that are predicted to be
damaging in genes of unknown function, focusing on genes with
indirect systems-level evidence of a role in the immune system.
The mutation of interest is then brought to homozygosity by
intercrossing heterozygous G2 carriers and then genotyping the
G3 offspring to identify the 25% expected to be homozygous
for the mutation of interest. These homozygotes and all their
G3 siblings are tested for a battery of immune phenotypes, and
the data are analyzed to detect phenotypic changes that segre-
gate with the mutation of interest.
Here we describe the use of a systems-guided forward genetics
screen to reveal that homozygous Etaa1 loss-of-function muta-
tions permitted normal mouse development, albeit with >50%
embryonic loss, had no discernable effect on T and B lymphocyte
development or T-cell proliferation in vitro but caused a pro-
found, cell-intrinsic decrease in T-cell proliferation in vivo in
response to immunization or viral infection. Early in the re-
sponse to virus infection, the rapidly dividing mutant T cells
display a strong induction of p53-induced DNA damage re-
sponse gene sets and increased γH2AX. These results, together
with four recent studies demonstrating that ETAA1 associates
with RPA at stalled DNA replication forks to stimulate ATR and
the replication stress response in nonlymphoid cancer cells in
tissue culture (18–21), reveal a highly specific role for ETAA1 in
adult mice regulating replication stress during the formation of
effector T cells after infection or immunization.
Results
Etaa1 Mutant Mice Have Defective Effector T-Cell Responses After
Vaccination. A systems-guided forward genetics screen was con-
ducted on de novo heterozygous point mutations revealed by
exome sequencing of hundreds of G1 offspring of ENU-treated
C57BL/6 male mice (16, 17). G1 mouse IGL1100 had an Etaa1
point mutation in the intron between exons 2 and 3, predicted to
be damaging because it substituted a C nucleotide for the essential
+2 T of the splice donor consensus sequence (Fig. 1A). After
outcrossing the G1 mouse with unrelated G1 mice to segregate
other unlinked heterozygous mutations, the G2 offspring were
genotyped to identify and intercross the 50% of animals hetero-
zygous for the Etaa1 mutation. The G3 offspring resulting from
the intercrosses were genotyped for the Etaa1 mutation to identify
homozygous, heterozygous, and wild-type siblings, which were
then screened for immune phenotypes.
Flow cytometry screening of blood samples from the G3 off-
spring revealed normal frequencies of lymphocytes and subsets of
B cells and CD4+ and CD8+ T cells in the Etaa1 mutant homo-
zygotes (see below). However, after challenge with an immuniza-
tion mixture of inactivated Bordetella pertussis and chicken gamma
globulin (CGG), the homozygous mutants failed to generate the
population of effector KLRG1hi CD4+ and CD8+ T cells normally
seen at day 14 postimmunization in the blood of wild-type mice
(Fig. 1 B and C). In further generations of outcrossing to C57BL/
6 mice and intercrossing Etaa1 heterozygotes, the lack of effector
T cells after immunization correlated completely with homozy-
gosity for the Etaa1mutation, whereas this trait segregated from all
other linked and unlinked mutations present in the original G1
IGL1100 founder mouse. The Etaa1 homozygous mutants also had
lower titers of T-cell–dependent antibody at 14 d after immuni-
zation (Fig. 1D), although this phenotype often reached compa-
rable titers to those seen in wild-type mice by 28 d.
Based on the striking effector T-cell deficit after immuniza-
tion, the molecular effect of the Etaa1 Exon 2 splice donor
mutation was determined by preparing spleen cDNA from ho-
mozygous mutant and wild-type littermates. PCR amplification
of Etaa1 cDNA with primers in exons 1 and 5 yielded a single
product of the expected size from wild-type cDNA, but yielded
two major and several minor aberrantly sized products from
mutant cDNA (Fig. 1E). Sequencing of the PCR products
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Fig. 1. Etaa1 is required for effector T-cell expansion after immunization and
LCMV infection. (A) Schematic of the Etaa1 gene, with exons numbered,
coding sequence in blue, and location of the ΔEx2 splice and C166X mutations.
(B–D) Representative and compiled data showing KLRG1hi effector T-cell per-
centage (B and C) and CGG antibody titer (D) in blood at day 14 after im-
munization of Etaa1+/+ or Etaa1ΔEx2/ΔEx2 mice with CGG and inactivated
B. pertussis. (E) Agarose gel electrophoresis of PCR-amplified cDNA using pri-
mers in Etaa1 exons 1 and 5 from Etaa1+/+ or Etaa1ΔEx2/ΔEx2 spleen cells. The
mRNA structure of the indicated bands deduced by Sanger sequencing is
shown on the right. (F) Wild-type or ΔEx2mutant Etaa1 cDNA sequences fused
to GFP were transiently transfected into HEK293T cells. Western blot analysis
was conducted on total cell lysates prepared at 48 h after transfection to as-
sess GFP-fused ETAA1 or control β-actin protein expression. (G) Etaa1+/+,
Etaa1C166X/C166X, or Etaa1ΔEx2/ΔEx2 mice were infected with LCMV-Arm, and the
numbers of splenic CD8+GP33–41, CD8
+NP396–404, and CD4
+GP66–77 tetramer-
positive cells were assessed at day 8 postinfection. The dotted line in each
graph indicates the limit of detection based on staining of uninfected animals.
***P < 0.001, t test (C and D) or one-way ANOVA (G).
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revealed one of the two main PCR products in the mutant mice
spliced exon 1 to exon 2 normally, but skipped the normal exon
2 splice donor, instead splicing to exon 3 from a cryptic splice
donor at +25 nucleotides in intron 2. The retained intronic
25 nucleotides encoded nine amino acids before an in-frame stop
codon, resulting in a truncated product containing only the first
77 amino acids of the 877-residue ETAA1 protein. The other
major product in the mutant mice was smaller than wild-type
because it skipped exon 2, splicing exon 1 to exon 3 to produce
an in-frame deletion of 42 amino acids (Gly78-Leu119 inclusive).
The third and largest sequenced product retained the entire
exon 2/3 intron, which also introduced the in-frame stop co-
don mentioned above. When the full length wild-type or exon
2-deleted Etaa1 sequence was expressed as GFP fusion proteins
in transiently transfected cells, they produced comparable
amounts of protein (Fig. 1F) that was localized primarily in the
nucleus in both cases. Because one of the main aberrantly spliced
products encodes all the ETAA1 protein except the 42 residues
encoded by exon 2, we refer to this Etaa1 mutant allele as ΔEx2.
An independent Etaa1 mutant allele was identified in the
exome sequence of another G1 mouse, IGL00465. This allele is a
point mutation in exon 4, changing the Cys166 codon sequence
from TGT to TGA to create a premature stop codon at amino
acid 166 of the 877-aa mouse ETAA1 protein (Fig. 1A). Thus, the
Etaa1C166X mutation would be predicted to result in a null allele.
To extend the T-cell analysis, mice homozygous for the two
different Etaa1 mutations were bred in parallel and infected with
lymphocytic choriomeningitis virus Armstrong (LCMV-Arm)
strain, which establishes an acute infection and provokes a ro-
bust and well-characterized T-cell response. The LCMV antigen-
specific T-cell response was assessed at the peak of the T-cell
response at day 8 postinfection. Thus, this test would resolve
whether the reduction in effector T cells observed at day
14 postimmunization in the Etaa1ΔEx2/ΔEx2 mutant mice was due
to defective initial clonal expansion or excessive contraction after
the peak of the response at day 7–8. In addition, because ter-
minally differentiated KLRG1hi effector T cells represent only
one subset of effectors (22, 23), testing for LCMV antigen-
specific T cells would resolve if the Etaa1 mutant mice had a
selective deficiency in the generation of KLRG1hi effectors or a
general defect in clonal expansion of antigen-specific T cells.
Flow cytometry staining with tetramers enabled enumeration
of CD8+ T cells specific for two immunodominant epitopes of
the virus, GP33–41 and NP396–404, and CD4
+ T cells specific for
the immunodominant GP66–77 virus epitope. Compared with
wild-type controls, there were 10-fold fewer antigen-specific
CD8+ and CD4+ T cells in LCMV-infected homozygotes for
either the exon 2 deleted or the C166X null allele, although
there was still a detectable effector T-cell response in both
strains (Fig. 1G). A similar decrease in effector cell number was
observed when antigen-specific T cells were enumerated by
peptide-stimulated IFN-γ expression. Despite this deficiency, no
virus was observed by plaque assay at day 8 postinfection in
mutant or wild-type mice (data not shown), suggesting the
presence of sufficient effector cells for viral control. Based on
this result, we conclude that ETAA1 deficiency, either by loss of
almost all the protein or by deletion of amino acids 78–119, re-
sults in a specific immune deficiency that preserves circulating
T-cell numbers but cripples their clonal expansion after infection
or immunization.
ETAA1 Deficiency Interferes with T-Cell Clonal Expansion Cell
Autonomously. Competitive bone marrow transplants were per-
formed to examine whether the immunologic effects of ETAA1
deficiency were T-cell intrinsic or secondary to abnormalities in
other cells within or outside the blood system. C57BL/6 Rag1−/−
mice, which lack T or B cells, were transplanted with an equal
mixture of bone marrow from Etaa1ΔEx2/ΔEx2 CD45.2+ C57BL/6 mice
and from Etaa1+/+ C57BL/6 mice bearing a congenic CD45.1 cell
surface marker. In parallel, control mixed BM chimeras were
transplanted with an equal mixture of bone marrow from Etaa1+/+
CD45.2+ and Etaa1+/+ CD45.1+ mice, so that the competing
transplanted cells had normal ETAA1. In competition with wild-
type CD45.1+ hematopoietic progenitors and lymphocytes,
CD45.2+ cells with normal ETAA1 accounted for ∼50% of lym-
phocytes, B cells, and naïve T cells in the reconstituted control
chimeras, whereas ETAA1-deficient CD45.2+ cells reconstituted
∼30% of the same lymphocyte compartments (Fig. 2A). In con-
trast, ETAA1-deficient CD45.2+ cells did not contribute to the
KLRG1hi effector CD4+ or CD8+ T cells in blood at 2 wk weeks
after immunization (even after normalizing for the poorer
ETAA1-deficient lymphocyte reconstitution), despite the forma-
tion of many effector T cells from the wild-type CD45.1+ cells in
the same animals (Fig. 2 B and C). In control mixed chimeras
analyzed in parallel, CD45.2+ cells with wild-type ETAA1 formed
effector T cells at only slightly less frequency than their CD45.1+
competitors (Fig. 2 B and C). These results demonstrate that
ETAA1 deficiency acts cell-autonomously within T cells to pro-
foundly cripple effector T-cell formation.
To extend this analysis to other subsets of antigen-induced T and
B cells, the mixed chimeras were immunized with sheep red blood
cells (SRBCs) to elicit germinal center (GC) reactions in the spleen
composed of rapidly dividing GC B cells and T follicular helper
(TFH) cells. Although large numbers of both subsets were formed in
each chimeric animal, they were derived mostly from wild-type cells;
even after normalizing for their slightly diminished contribution to
B cells and CD4 naïve T cells, ETAA1-deficient CD45.2+ cells
accounted for only 30% of the GC B cells and 6% of TFH cells
(Fig. 2D). In control chimeras, CD45.2+ cells with wild-type
ETAA1 accounted for 50% of the GC B cells and TFH cells (Fig.
2D; also normalized for reconstitution). Thus, ETAA1 deficiency
also acts cell-autonomously to profoundly compromise TFH cell
formation, and has only a modest cell-autonomous effect on GC B-
cell accumulation.
The cell-autonomous effect of ETAA1 deficiency also was
demonstrated at the level of antigen-specific T cells by infecting
mixed bone marrow chimeras with LCMV-Arm and measuring the
contribution of CD45.2+ cells to tetramer-binding CD8+ and CD4+
T cells at day 8 postinfection. Again, a profound and specific de-
ficiency in antigen-specific T-cell accumulation was observed in
ETAA1-deficient CD45.2+ cells, but not in wild-type CD45.2+ cells,
in control mixed chimeras (Fig. 2E). A similar decrease in effector
cell number was observed when antigen-specific T cells were enu-
merated by peptide-stimulated IFN-γ expression.
Partial Embryonic Lethality and Smaller Body Size in ETAA1-Deficient
Mice. Two significant observations were made during further
breeding of Etaa1 mutant heterozygotes and homozygotes:
(i) Etaa1ΔEx2/ΔEx2 homozygous male mice had comparable fecun-
dity to wild-type C57BL/6 mice (Fig. 3A; the fecundity of homo-
zygous females was not assessed), and (ii) homozygous mutant
mice were born at a lower frequency than expected (Table 1). In
Etaa1ΔEx2/+ × Etaa1ΔEx2/+ mouse crosses, only 6.8% of offspring
were homozygous mutants, rather than the expected 25%. A
similarly decrease was seen in the the frequency of homozygous
mutants born from intercrosses of Etaa1C166X/+ mice (Table 1). In
Etaa1ΔEx2/ΔEx2 × Etaa1ΔEx2/+ crosses, homozygous mutant mice
were born at a 20% frequency instead of the expected 50%. Thus,
ETAA1 deficiency appears to result in partially penetrant embry-
onic lethality. Nevertheless, Etaa1ΔEx2/ΔEx2 homozygous embryos
were present at the expected rate at embryonic day 12 (Table 1),
indicating that homozygous lethality occurs after this stage of de-
velopment, in contrast to the blastocyst-stage lethality caused by
homozygous null mutations in Rpa1, Atr, and Topbp1 (9–13).
Along with being fertile, homozygous mutant mice that were
born lacked discernable pathology. Homozygotes had slightly de-
creased mean body weight and length, with decreased body mass
index (BMI) evident in older mice (Fig. 3B). In a cohort of mice
aged >1 y, there was no evidence of increased mortality in the
Etaa1ΔEx2/ΔEx2 homozygous mice (Fig. 3C), and a comprehensive
pathological analysis of these mice failed to reveal any obvious
abnormality (SI Appendix). T-cell developmental subsets were
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present in normal numbers in the thymus of mutant mice, and
there were normal numbers of peripheral T-cell subsets (Fig. 3D).
Thus, the only striking abnormality caused by ETAA1 deficiency in
adult mice is the profound failure to accumulate effector T cells.
ETAA1-Deficient T Cells Differentiate into Effectors Despite Poor
Clonal Expansion. The diminished accumulation of antigen-
specific T cells after systemic infection with LCMV (Figs. 1
and 2) also occurred when ETAA1-deficient mice were infected
with herpes simplex virus type 1 (HSV1) by tattoo inoculation of
shaved flank skin (24) (Fig. 4 A and B). Nonetheless, ETAA1-
deficient mice displayed normal control of HSV1 in the skin and
in the nervous system, as shown by lack of neurologic symptoms
and typical-sized lesions at primary and secondary skin sites (Fig.
4C). Because effector T cells are required to control HSV1 (25,
26), the smaller populations of effector T cells (Fig. 4 A and B)
nevertheless appear to be active in vivo.
As noted above, the diminished effector T-cell population in
LCMV-infected ETAA1-deficient mice appeared sufficient to
clear infection by day 8 postinfection. Detailed flow cytometry
phenotyping of the LCMV tetramer-specific CD8+ T cells at this
timepoint revealed that the effector CD8+ T cells that did form
exhibited relatively normal effector differentiation despite some
alterations in effector subset composition (Fig. 5 A–D); in fact, if
anything the mutant cells had slightly greater effector function,
as evidenced by slightly elevated production of IFN-γ and
granzyme B (GzmB). Similarly, the effector CD4+ T cells that
formed exhibited normal subset differentiation (27) except for a
slight decrease in PSGL1lo TFH cells (Fig. 5E). Cytokine function
also was normal in these effector CD4+ T cells, again with
slightly enhanced cytokine function within mutant effectors.
ETAA1-Deficient T Cells Proliferate Normally in Vitro and in Vivo. To
understand why a smaller population of effector T cells was formed
from ETAA1-deficient precursors, we needed to track the preceding
phase of naïve T-cell activation and division at early time points after
virus infection. To track CD8+ T cells bearing a defined T-cell re-
ceptor (TCR) for virus antigen, we crossed the Etaa1ΔEx2 allele to
congenically marked (CD45.1+) P14 TCR transgenic C57BL/6 mice,
which express a TCR specific for LCMV GP33–41 antigen. Naïve
CD8+ T cells expressing the P14 TCR developed and accumu-
lated normally despite ETAA1 deficiency. We then transferred 5 ×
104 Etaa1+/+ or Etaa1ΔEx2/ΔEx2 CD45.1+ P14 CD8+ T cells into
CD45.2+ C57BL/6 mice with normal ETAA1, and infected the re-
cipients with LCMV-Arm. Despite having the same starting naïve
P14 precursor frequency, 10-fold fewer mutant than wild-type P14
CD8+ T-cell progeny accumulated in the spleen by day 5 post-
infection, and 100-fold fewer accumulated by day 8 (Fig. 6A). Im-
portantly, the decrease in the number of mutant P14 cells observed
within the spleen was not due to migration to other organs, given
that similar deficiencies in mutant P14 cell numbers were seen in the
lymph nodes, bone marrow, lung, and liver (Fig. 6B).
These results indicate that the decreased clonal expansion of
ETAA1-deficient T cells was related either to decreased T-cell
division or to decreased survival of the dividing progeny. We first
examined T-cell division and survival in vitro after stimulation.
Polyclonal T cells from the spleen of CD45.2+ Etaa1ΔEx2/ΔEx2
mice or CD45.1+ wild-type controls were labeled with the
division-tracking dye Cell Trace Violet (CTV) and stimulated
with anti-CD3 for 3–4 d. Strikingly, the mutant T cells exhibited
normal cell division after stimulation, with similar results
obtained over a range of anti-CD3 doses with or without anti-
CD28 (Fig. 6C). To test in vitro proliferative capacity following
antigen-specific stimulation, we stimulated Etaa1+/+ or Etaa1-
ΔEx2/ΔEx2 P14 CD8+ T cells with GP33–41 peptide and IL-2 in vitro
and analyzed them daily for 5 d. ETAA1-deficient P14 cells ac-
quired the Ki67 cell cycle marker and increased in number com-
parably to their wild-type counterparts, and also exhibited a
comparable percentage of viable cells at each time point (Fig. 6D),
demonstrating that ETAA1 is dispensable for clonal expansion
in vitro.
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Fig. 2. Etaa1 control of effector T-cell expansion is cell intrinsic. Rag1−/− mice
were lethally irradiated and reconstituted with a 50:50 mixture of CD45.1+ wild-
type bone marrow and CD45.2+ Etaa1+/+ or Etaa1ΔEx2/ΔEx2 bone marrow.
(A) Contributions of CD45.2+ Etaa1+/+ and Etaa1ΔEx2/ΔEx2 cells to total lympho-
cytes, B cells, and T cells in competitive mixed bone marrow chimeras, measured
in blood before immunization or infection. (B and C) Wild-type and mutant
mixed bone marrow chimeras were immunized with CGG and inactivated
B. pertussis, and blood was analyzed at day 28 postimmunization. (B) Repre-
sentative plots showing the percentage of CD45.2+ and CD45.1+ cells falling
within the KLRG1hi effector T-cell gate. (C) %CD45.2+ cells among all KLRG1hi
effector T cells in individual wild-type or mutant mixed bone marrow chimeras.
To correct for individual differences in overall reconstitution by CD45.2+marrow
inA, each postimmunization value was normalized to the%CD45.2+ cells among
all CD4 or CD8 cells in the same chimeric mouse before immunization.
(D) %CD45.2+ cells within germinal center B cells (GC; B220+GL-7+CD95+) and TFH
cells (CD4+PD-1hiCXCR5hi) in the spleen on day 7 postimmunization with SRBCs,
normalized to the %CD45.2+ cells in all B cells or to the CD4 T cells in the same
chimera before immunization. (E) %CD45.2+ splenic cells within the CD8+GP33–41,
CD8+NP396–404, and CD4
+GP66–77 tetramer-positive cells at day 8 postinfection
with LCMV-Arm in either wild-type or mutant mixed bone marrow chimeras,
normalized to the %CD45.2+ cells among all CD8 cells in the same chimera be-
fore infection. ***P < 0.001, **P < 0.01, t test.
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These experiments showed that ETAA1-deficient T cells di-
vide normally in tissue culture. We next tested whether ETAA-
deficient T cells divide normally in vivo, by CTV-labeling naïve
CD45.1+ Etaa1+/+ and Etaa1ΔEx2/ΔEx2 P14 CD8+ T cells before
injecting them into the circulation of wild-type CD45.2+ C57BL/
6 mice that were subsequently infected with LCMV-Arm. When
CTV dilution was analyzed in CD45.1+ CD8+ T cells in the
spleen at 60 h after infection, the same proportion of P14 cells
had divided whether they were ETAA1-deficient or wild-type,
and those cells that had divided exhibited a similar CTV mean
fluorescence intensity (MFI) (Fig. 6E). Although CTV was
completely diluted from all P14 cells by day 5 postinfection, there
were comparable percentages of Ki67+ cells in cycle (Fig. 6F)
despite the 10-fold reduction in mutant P14 numbers at this time
point (Fig. 6A). Determination of the proportion of P14 cells that
were dead and/or apoptotic at this time point by flow cytometry
using Annexin V and fixable live/dead dye staining revealed no
consistent difference despite a variable trend toward slightly more
death within mutant cells. Given that cell death in vivo can be
difficult to detect due to rapid apoptotic cell clearance, the normal
division observed in these experiments favor the conclusion that
ETAA1-deficient T cells have decreased clonal expansion due to
impaired survival of dividing progeny.
ETAA1-Deficient T Cells Accumulate Elevated Levels of DNA Damage.
We performed gene expression analysis by RNA sequenc-
ing (RNA-seq) to test for differences that might explain why
ETAA1-deficient dividing P14 T cells have diminished survival
during their proliferative response to viral antigen in infected
mice. As above, Etaa1+/+ or Etaa1ΔEx2/ΔEx2 CD45.1+ P14 cells
were injected into wild-type C57BL/6 mice and the recipients
infected with LCMV. CD45.1+ CD8+ P14 progeny were purified
from the spleen by fluorescence activated cell sorting on day
5 postinfection, when the clonal expansion defect first becomes
evident. cDNA libraries from four pools of sorted mutant or
wild-type P14 cells, isolated from independent sets of recipient
mice, were analyzed by massively parallel RNA-seq. Using
edgeR (28), 109 differentially expressed genes were identified,
including 94 that were increased in mutant P14 cells compared
with wild-type (Table S1). Gene set enrichment analysis (GSEA)
(29) of the RNA-seq data indicated that the gene set of TP53
(p53)-induced genes was significantly enriched within up-
regulated mRNAs in mutant cells (Fig. 7A). Gene Ontology
(GO)/Kyoto Encyclopedia of Genes and Genomes (KEGG)
enrichment analysis of the 94 genes up-regulated in mutant cells
using g:Profiler (30) yielded strong evidence of up-regulation of
p53-linked genes, particularly genes associated with p53-
mediated apoptosis and also genes generally associated with
0 100 200 300 400 500
0
20
40
60
80
100
Days
Pe
rc
en
t s
ur
vi
va
l
Et
aa
1
Ex
2/+
Et
aa
1
Ex
2/
Ex
2
0
10
20
30
40
50
N
um
be
r o
f p
up
s
ns
10-2
10-1
100
101
102
103
C
el
l n
o.
 (x
10
-6
)
DN DP CD4 SP CD8 SP
ns
ns ns
ns
10-2
10-1
100
101
102
C
el
l n
o.
 (x
10
-6
)
Naive Tcm Tem
ns
**
ns
10-2
10-1
100
101
102
C
el
l n
o.
 (x
10
-6
)
Naive Tcm Tem
ns
ns
nsns
Treg
A B 
0
20
40
60
80
100
Le
ng
th
 (m
m
)
**
0
10
20
30
40
W
ei
gh
t (
g)
ns
0
1
2
3
4
5
BM
I
ns
0
20
40
60
80
100
Le
ng
th
 (m
m
)
**
0
10
20
30
40
50
W
ei
gh
t (
g)
**
0
1
2
3
4
BM
I
*
8-12  
weeks 
1 year 
C D Thymic T cells Splenic CD8+ T cells Splenic CD4+ T cells 
+/+ 
Ex2/ Ex2 
+/+ 
Ex2/ Ex2 
+/+ 
Ex2/ Ex2 
+/+ 
Ex2/ Ex2 +/+ Ex2/ Ex2 
+/+   (n=12) 
Ex2/+  (n=18) 
Ex2/ Ex2  (n=15) 
Fig. 3. Etaa1-deficient mice display little or no steady-state phenotype. (A) Fecundity of male Etaa1ΔEx2/ΔEx2 mice vs. male Etaa1ΔEx2/+ controls, expressed as
the number of pups sired per male over a 6-mo period. (B) Length, weight, and BMI of young (8–12 wk) or old (1 y) Etaa1+/+ or Etaa1ΔEx2/ΔEx2 mice. (C) Survival
curves of Etaa1+/+, Etaa1ΔEx2/+, and Etaa1ΔEx2/ΔEx2 mice. (D) Numbers of thymic (Left) and splenic (Right) T-cell subsets, defined as follows: double-negative
(DN), B220−CD4−CD8−; double-positive (DP), B220−CD4+CD8+; CD4 single-positive (SP), B220−CD4+CD8−; CD8 SP, B220−CD4−CD8+; naïve, CD4+ or CD8+ and
CD62LhiCD44lo; Tcm, CD4
+ or CD8+ and CD62LhiCD44hi; Tem (or effector), CD4
+ or CD8+ and CD62LloCD44hi; and Treg, CD4+Foxp3+CD25int-hi. **P < 0.01; *P <
0.05; ns, not significant by t test.
Table 1. Frequencies of Etaa1-deficient mouse strain genotypes
Cross WT Heterozygote Mutation P value
ΔEx2/+ × ΔEx2/+ 32.5% (326/1,002) 60.7% (608/1,002) 6.8% (68/1,002) < 0.0001
ΔEx2/+ × ΔEx2/ΔEx2 NA 79.7% (126/158) 20.3% (32/158) < 0.0001
ΔEx2/+ × ΔEx2/+ (E12 embryos) 25.5% (25/98) 52% (51/98) 22.5% (22/98) 0.9385
C166X/+ × C166X/+ 32.5% (53/163) 62.6% (102/163) 4.9% (8/163) < 0.0001
NA, not applicable.
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apoptosis pathways (Table 2). Independently, p53-binding sites
were significantly enriched within the genes up-regulated in
Etaa1ΔEx2/ΔEx2 P14 cells (Table S2).
Because TP53 activity is induced by DNA replication stress and
DNA damage, accompanied by ATR or ATM kinase activation,
we used flow cytometry to measure Ser139-phosphorylated H2AX
(γH2AX) within mutant and wild-type P14 cells proliferating in
LCMV-infected recipient mice. ETAA1-deficient P14 CD45.1+
CD8+ T effector cells had increased γH2AX staining relative to
wild-type control P14 cells on both day 5 and day 8 postinfection
(Fig. 7 B and C). In contrast, when P14 cells were stimulated to
divide in tissue culture, using the conditions and time points above
that showed no decrease in P14 accumulation in vitro, there was
no evidence of increased γH2AX staining within mutant P14
T cells. Thus, ETAA1 deficiency causes a selective decrease in the
survival of dividing T cells in vivo, but not in tissue culture, that is
correlated with increased phosphorylation of ATR/ATM sub-
strates in vivo, but not in tissue culture.
Discussion
Here we identify a specific immune response function for ETAA1,
which was an obscure pioneer protein at the time that we initiated
and performed these studies. ETAA1’s immunological function
was revealed by a genetic screening strategy that merges elements
of forward (phenotype-driven) genetics and reverse (gene-driven)
genetics. Randomly induced mutations in the mouse germ line
were identified by exome sequencing before phenotypic screening,
so that breeding and phenotyping could focus on prioritized mu-
tations with possible immune effects based on gene expression
patterns or other systems-level information. Our analysis of mouse
mutants with a null allele or an exon 2 deletion allele indicates
that in adult animals, ETAA1 is selectively required to suppress
the DNA damage response in rapidly proliferating effector T cells
during an immune response. These immunologic findings are com-
plemented by four papers published at the end of 2016 identifying
ETAA1 as a functional component of the ATR-activating rep-
lication stress response complex in human cancer cell lines, with
exon 2 encoding the ATR-activating domain of ETAA1 (18–21).
This advance represents a striking demonstration that specific,
rate-limiting pathways are needed to insulate proliferating ef-
fector T cells against replication stress that might be targeted for
suppression of transplant rejection, graft-vs.-host disease, and
autoimmune disease.
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Fig. 5. Etaa1-deficient T cells differentiate into functional effector cells. Etaa1+/+ and Etaa1ΔEx2/ΔEx2 mice were infected with LCMV-Arm, and at day
8 postinfection either CD8+GP33–41 (A–D) or CD4
+GP66–77 (E ) tetramer-positive cells were assessed for short-lived effector (CD127
loKLRG1hi) and memory
precursor (CD127hiKLRG1lo and potentially CD62Lint-hi) markers (A and B), effector function (GzmB expression and IFN-γ, TNFα, and IL-2 production)
(C and D), and TH1 (PSGL1
hiLy6Chi), CD4 memory precursor (PSGL1hiLy6Clo) and TFH (PSGL1
lo) differentiation (E ). ***P < 0.001; **P < 0.01; ns, not sig-
nificant, t test.
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The pattern of Etaa1 mRNA expression on BioGPS (15) was
the primary a priori evidence suggesting a possible immune
system function, and this pattern is broadly consistent with the
effects seen in homozygous mutant mice. Etaa1 mRNA is highest
in embryonic stem cells, consistent with the observed partial em-
bryonic lethality, although lethality occurs after embryonic day 12.
Etaa1 is next most highly expressed in T and B lymphocytes,
consistent with the observed profound decrease in effector T-cell
accumulation. Aside from a subtle decrease in body size, homo-
zygous mice that were born did not display any tissue pathology or
increased mortality, were fertile, and males successfully sired
multiple litters of offspring. Within the immune system, Etaa1
mRNA is nevertheless expressed at comparable levels in many
subsets of developing, mature, and activated T, B, natural killer,
and dendritic cells and also in hematopoietic stem and pro-
genitor cells (probeset 10384486; www.immgen.org/) (31), yet
surprisingly the effects of ETAA1 deficiency were restricted to
mature T cells after they had been activated by antigen and had
started to rapidly divide in vivo. Earlier stages of blood cell
progenitor and T-cell and B-cell progenitor proliferation in the
thymus and bone marrow, and naïve T-cell and B-cell accumu-
lation in the blood and spleen, were largely unaffected by
ETAA1 deficiency in homozygous mutant mice and in competitive
mixed bone marrow transplants. In contrast to the profound cell-
autonomous decrease in ETAA1-deficient TFH cell accumulation in
immunized mixed bone marrow chimeras, accumulation of ETAA1-
deficient GC B cells in the same chimeras displayed only a subtle
cell-autonomous decrease.
Within rapidly dividing T cells responding to virus infection in
vivo, we delineated the effect of ETAA1 deficiency by showing that
it does not diminish their rate of division or differentiation, but
increases their levels of Ser-139 phosphorylated H2AX and ex-
pression of TP53-induced mRNAs. As discussed below, this finding
directly aligns with the recently published identification of a bio-
chemical function for ETAA1 as an activator of ATR kinase and
the replication stress response in human cancer cell lines (18–21).
During DNA replication, unwinding by MCM family DNA
helicases exposes the leading and lagging strands as ssDNA,
which are bound and prevented from reannealing by RPA pro-
teins. Tight regulation is required to ensure that both strands of
ssDNA are converted into dsDNA by replicase complexes at the
same pace as the helicase unwinds unreplicated DNA. The
master regulator is ATR kinase, and, consequently, ATR genetic
deficiency in mice results in completely penetrant embryonic
lethality and failure of inner mass cell proliferation at the blas-
tocyst stage (9, 10). Partial loss of function ATRmutations causes
Seckel syndrome in humans and a similar condition when in-
troduced into mice (12), characterized by microcephaly,
dwarfism, bone marrow failure, and (in mice) incompletely
penetrant embryonic lethality. ATR is recruited to replication
forks by its association with ATR-Interacting Protein (ATRIP),
which binds to RPA on ssDNA. Phosphorylation by ATR is
activated if there is replication stress causing the replication
fork to collapse or stall. Replication stress can arise from fac-
tors as simple as deoxyribonucleotide shortage, which can be
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Fig. 6. Etaa1-deficient T cells exhibit normal proliferation and tissue mi-
gration. (A and B) CD45.2+ C57BL/6 mice were injected i.v. with 5 × 104
CD45.1+ Etaa1+/+ or Etaa1ΔEx2/ΔEx2 P14 cells before infection with LCMV-Arm.
(A) Splenic P14 cells enumerated at days 5 and 8 postinfection showing mean
and SD (n = 10–14/group). (B) P14 numbers in the indicated tissues on day
8 postinfection (C) CD45.1+ wild-type and CD45.2+ Etaa1ΔEx2/ΔEx2 splenocytes
were mixed in a 50:50 ratio, labeled with CTV, and stimulated with 1 μg/mL
anti-CD3. Then 3–4 d later, CTV dilution in CD4+ and CD8+ T cells from wild-
type (CD45.1+) and mutant (CD45.2+) cells was compared. (D) Etaa1+/+ and
Etaa1ΔEx2/ΔEx2 P14 cells were stimulated in vitro with GP33–41 peptide and IL-2,
live P14 cells were enumerated (expressed as fold change over starting cell
number), and Ki67 expression and viability (% 7AAD− Live/Dead dye−) were
measured by flow cytometry at each timepoint. (E) CD45.2+ C57BL/6 mice
were injected i.v. with 8 × 105 CTV-labeled CD45.1+ Etaa1+/+ or Etaa1ΔEx2/ΔEx2
P14 cells before infection with LCMV-Arm. At day 2.5 postinfection, CTV
dilution in the transferred P14 cells was measured by flow cytometry, with
the CTV MFI in divided P14 cells from each mouse normalized to the average
MFI in wild-type P14 cells in the same experiment. Data are pooled from two
experiments. (F) The percentage of Ki67+ P14 cells at day 5 postinfection in
the experiment outlined in A and B. ***P < 0.001; ns, not significant, two-
way ANOVA (A) or t test (B, E, and F).
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Fig. 7. Etaa1-deficient T cells have an enhanced DNA damage response.
CD45.2+ C57BL/6 mice were injected i.v. with 5 × 104 CD45.1+ Etaa1+/+ or
Etaa1ΔEx2/ΔEx2 P14 cells before infection with LCMV-Arm. (A) The Etaa1+/+
and Etaa1ΔEx2/ΔEx2 P14 cells were sorted at day 5 postinfection, and gene
expression was analyzed by RNA-seq. The plot shows GSEA demonstrating a
significant up-regulation of the p53 (TP53)-induced genes within the ranked
RNA-seq data (ordered from most up-regulated to most down-regulated in
mutant vs. wild-type cells). NES, normalized enrichment score; FDR q, false
discovery rate q score. (B and C) Representative and compiled data of γH2AX
staining within Etaa1+/+ and Etaa1ΔEx2/ΔEx2 P14 cells at day 5 (B and C) and
day 8 (C) postinfection ***P < 0.001, t test.
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experimentally or clinically induced by inhibiting ribonucleo-
tide reductase with the drug hydroxyurea. Replication stress
also can arise when the replicase encounters DNA damage; for
example, single-strand nicks created by the DNA torsion-
releasing activity of Topoisomerase 1 upstream of the heli-
case, which fail to be repaired in the presence of the anticancer
drug camptothecin and result in dsDNA breaks if the replica-
tion fork collides with the nick.
During physiological replication stress, collapsed forks release
the replicase complex and expose junctions between ssDNA and
replicated dsDNA that recruit the PCNA-like Rad9-Rad1-Hus1
(9-1-1) protein complex. The 9-1-1 complex together with other
proteins recruits TOPBP1, and TOPBP1 contains an ATR-activating
domain with a critical residue, W1147, that binds ATR and stimu-
lates its kinase activity (32). TOPBP1 appears to be the primary
ATR activator under physiological mammalian cell replication, be-
cause homozygous null mutations or W1147 point mutations in mice
result in early embryonic lethality at the blastocyst stage, phenoco-
pying null mutations in Atr (11, 33).
The recent studies of ETAA1 in human cancer cell lines reveal
that ETAA1 serves as an activator of ATR in parallel with
TOPBP1 (18–21), but likely acts primarily at stalled replication
forks with extended ssDNA segments coated by RPA that are too
distant to the ssDNA-dsDNA replication junctions for TOPBP1
recruitment. The studies identify RPA-binding domains in the
middle and C terminus of ETAA1, and an ATR activation domain
in the N terminus encoded by exon 2 and containing a critical
W107 residue (corresponding to W109 in mouse). Cancer cell
lines lacking ETAA1 had normal rates of cell division but in some
but not other cancer lines the loss of ETAA1 resulted in slower
and assymetrical progress of replication forks from sites of initi-
ation and slightly increased H2AX Ser139 phosphorylation (18–
21). These biochemical phenotypes of ETAA1-deficient cancer
cells were greatly exaggerated by increasing replication stress with
hydroxyurea or camptothecin, resulting in overt loss of cell via-
bility. Combined treatment with hydroxyurea to inhibit replicase,
and drugs to inhibit ATR, trigger replication fork breakage
resulting in dsDNA breaks that activate the related protein kinase,
Ataxia Telangiectasia Mutated (ATM), to phosphorylate H2AX
and induce TP53. Thus, ATM activation by dsDNA breaks also
may account for the increased H2AX in ETAA1-deficient cancer
cell lines and in effector T cells in vivo, as well as the induction of
TP53-response genes in effector T cells. The cancer cell pheno-
types were equally severe when the cells were engineered to have a
point mutation in the ETAA1 exon 2 splice acceptor, so that exon
2 was skipped to delete 42 amino acids from the ATR-activating
domain including W107, despite the cells’ production of normal
amounts of RPA-binding ETAA1 (18). These results provide a
biochemical explanation for the equally severe effector T-cell
deficiency observed here in mice with an exon 2 skipping mutation
or a truncating null mutation. Although we have not confirmed
that the exon 2 deleted protein is made in mouse T cells, as is the
case in human cell lines with an exon 2 skipping mutation (18), it
nevertheless is reasonable to infer from these results that ATR
activation is the critical function provided by ETAA1 in rapidly
dividing T cells in vivo.
Given the evidence that ETAA1 and TOPBP1 work in parallel
and cooperatively to activate ATR in cancer cells in tissue culture,
it is surprising that a homozygous ETAA1 deficiency in mice did
not produce the fully penetrant early embryonic lethality caused
by TOPBP1 or ATR deficiency. Unlike ATR and TOPBP1 de-
ficiency, homozygous lethality occurred after embryonic day 12 in
ETAA1-mutant embryos, indicating a relatively late block in de-
velopment. Even when ATR is conditionally inactivated in a
subset of cells in adult mice, it causes profound depression of bone
marrow and thymus cellularity and graying of hair, along with
selective loss of ATR-deficient cells from bone marrow and thy-
mus, in chimeric animals (34); however, these parameters were
relatively normal in ETAA1-deficient mice and mixed bone
marrow chimeras. TOPBP1 conditional deletion in developing B
or T cells results in almost complete absence of pre-B and mature
B cells and greatly decreased numbers of DP and SP thymocytes
and mature T cells (35), whereas B-cell and T-cell development
was at most only slightly decreased in ETAA1-deficient mice only
under competitive repopulation conditions.
Perhaps the closest parallel to the phenotype of mice with
ETAA1 deficiency is with mice homozygous for the ATR partial
loss-of-function Seckel mutation (12). Atrseckel homozygous mice
were born at one-half the expected frequency, similar to the
incompletely penetrant embryonic lethality in ETAA1-deficient
mice. However, adult Atrseckel homozygotes were microcephalic,
micrognathic, and dwarf (only one-third the weight of their wild-
type siblings), whereas ETAA1-deficient mice exhibited 90% of
the weight and length of wild-type controls with a normal cranial
appearance. Atrseckel homozygotes have increased numbers of
cells with phosphorylated H2AX foci and TP53 induction in
histological sections throughout E13.5 embryos, consistent with
exaggerated replicative stress, although this was not apparent in
tissues from adult mutant mice, including brain, colon, pro-
liferating B cells, stomach, liver, and lung. The adult Atrseckel
homozygotes died within 6 mo and exhibited severe pancytope-
nia, whereas ETAA1-deficient mice showed no apparent in-
crease in mortality and normal blood cells. Considered together
with the loss of ATR-deficient marrow cells in adult chimeric
animals (34), ETAA1 appears to not be the rate-limiting acti-
vator for ATR during the rapid cell division of adult hemato-
poiesis and lymphopoiesis.
One of the most important questions raised by our data is why
ETAA1 regulates replication stress under such restricted and
specific circumstances in dividing effector T cells in vivo, but not
in vitro. The simplest explanation is that ETAA1 becomes rate-
limiting for ATR activation only in cells that proliferate excep-
tionally rapidly; in all other situations, Topbp1 can compensate
for Etaa1 loss. Effector T cells proliferate in vivo at a much faster
rate compared with T cells in vitro, and in fact have one of the
fastest proliferation rates recorded (3). Interestingly, the only
other cell type reported to proliferate at a rate comparable to
effector T cells in vivo are dividing cells during mouse embryonic
Table 2. GO/KEGG terms enriched in genes up-regulated within
Etaa1ΔEx2/ΔEx2 P14 cells
GO/KEGG term GO/KEGG ID P value
p53-signaling pathway KEGG: 04115 0.00000231
Positive regulation of cellular metabolic
process
GO: 0031325 0.0000114
Positive regulation of macromolecule
metabolic process
GO: 0010604 0.0000129
Cytokine–cytokine receptor interaction KEGG: 04060 0.0000261
Positive regulation of metabolic process GO: 0009893 0.0000391
Positive regulation of cellular process GO: 0048522 0.000105
Positive regulation of programmed cell
death
GO: 0043068 0.00018
Positive regulation of cell death GO: 0010942 0.000308
Response to external stimulus GO: 0009605 0.000343
Cell activation GO: 0001775 0.000461
Positive regulation of biological process GO: 0048518 0.000469
Intrinsic apoptotic signaling pathway by
p53 class mediator
GO: 0072332 0.000476
Leukocyte activation GO: 0045321 0.000532
Positive regulation of protein metabolic
process
GO: 0051247 0.000666
Apoptotic signaling pathway GO: 0097190 0.000846
Positive regulation of nucleic
acid-templated transcription
GO: 1903508 0.00122
Positive regulation of transcription,
DNA-templated
GO: 0045893 0.00122
Regulation of apoptotic process GO: 0042981 0.00123
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development (3, 36), and indeed the only other phenotype ob-
served in Etaa1-deficient mice is partial embryonic lethality.
Our findings have several clinical implications. Given the selec-
tive phenotype observed in Etaa1-deficient mice, it is possible that
ETAA1 mutations in humans cause selective deficiency of effector
T cells that might have a nonsyndromic clinical presentation of
variable opportunistic infections. Indeed, a previous statistical as-
sociation between human ETAA1 polymorphisms and the risk of
pancreatic cancer (37) could be related as much to compromised
immunosurveillance downstream of impaired ETAA1 protein
function as to increased cellular transformation due to genomic
instability. Furthermore, given the selective phenotype seen in the
absence of ETAA1, transient targeting of ETAA1, or its interac-
tions with other components of the replication stress response, may
represent a novel strategy for depleting proliferating, autoreactive
T cells in organ or bone marrow transplantation or in autoimmune
disease. Further work is clearly needed to investigate the clinical
relevance and potential of this pathway.
Methods
Mice. Etaa1ΔEx2/ΔEx2 and Etaa1C166X/C166X mice were chosen from a list
of random single-nucleotide variants generated by ENU mutagenesis
(databases.apf.edu.au/mutations) and bred to homozygosity at generation 3
(17). C57BL/6 NCrl (C57BL/6), B6.SJL-Ptprca Pepcb/BoyJ (CD45.1), and
B6.129S7-Rag1tm1Mom/J (Rag1−/−) mice were purchased from the Australian
Phenomics Facility. P14 transgenic animals have been described previously (38).
For animal BMI studies, BMI was defined as weight in kilograms/length in meters
squared. A detailed pathological analysis of tissue sections was performed by the
Australian Phenomics Network Histopathology and Organ Pathology Service. All
animals used in this study were cared for and used in experiments in accordance
with protocols approved by the Australian National University Animal Experi-
mentation Ethics Committee and the current guidelines from the Australian
Code of Practice for the Care and Use of Animals for Scientific Purposes.
Infections, Immunizations, and Plaque Assays. Mice were infected with LCMV-
Arm by i.p. injection with 2 × 105 pfu of virus. LCMV viral plaque assays were
conducted as described previously (39). For HSV1 infections, mice were first
anesthetized by an i.p. infection of Avertin (20 μL/g of body weight), then
tattooed with HSV1 (1 × 108 pfu/mL) in a 0.5 × 0.5-cm2 area of shaved,
depilated skin on the left flank. Lesions were measured daily. CGG plus
inactivated B. pertussis immunizations were conducted as described pre-
viously, except that CGG was not conjugated to the hapten ABA (40). CGG
antibody levels were measured by ELISA on CGG-coated plates (Jackson
ImmunoResearch), and were detected with an IgG1 antibody (1070-04;
Southern Biotech). For SRBC immunization, mice received a 200-μL i.v. in-
jection of 2 × 108 SRBCs (Alsevers) diluted in PBS.
Flow Cytometry Staining and Analysis. Blood was prepared for flow cytometry
as described previously (16). Single-cell suspensions were prepared for flow
cytometry from spleen, thymus, and lymph nodes by passing the cells through a
70-μm cell strainer. Bone marrow was prepared by flushing the bone marrow
cells out of a single femur using a 26 G needle. Liver and lung cells were pre-
pared as described previously (41). Tetramer staining and intracellular cytokine
staining were performed as described previously (42, 43). For γH2AX staining,
cells were first stained with LIVE/DEAD Fixable Aqua Dead Cell Stain Kit (Life
Technologies) before fixation and permeabilization using the BD PhosFlow Kit
(Fix Buffer I and Perm Buffer III) according to manufacturer’s instructions (BD
Biosciences). Cells were then stained with γH2AX antibody (clone 2F3; Biol-
egend), with dead cells excluded from the analysis. The following antibodies
were used for staining (purchased from Biolegend unless stated otherwise):
CD8α (clone 53-6.7), CD4 (clone RM4-5), CD44 (clone IM7), KLRG1 (clone 2F1),
IFN-γ (clone XMG1.2), TNF-α (clone MP6-XT22), IL-2 (clone JES6-5H4), CD127
(clone A7R34), Ly6C (clone AL21; BD Biosciences), PSGL1 (clone 4RA10; BD
Biosciences), CD45.1 (clone A20), CD45.2 (clone 104), CD62L (clone MEL14),
Foxp3 (clone FJK-16s; eBioscience), CD25 (clone PC61), GzmB (clone GB11;
Thermo Fisher Scientific), Ki67 (clone B56; BD Biosciences), B220 (clone RA3-
6B2), PD-1 (clone RMP1-30), CXCR5 (clone 2G8; BD Biosciences), GL-7, and
CD95 (clone Jo2; BD Biosciences). MHCI LCMV tetramers were purchased from
the Biomolecular Resource Facility of the John Curtin School of Medical Re-
search, Australian National University, and the H-2Kb/gB498–505 dextramer was
purchased from Immudex. The MHCII GP66–77 tetramer was obtained from the
National Institutes of Health’s Tetramer Core Facility. Samples were acquired
using an LSRII, Fortessa or X20 flow cytometer (BD Bioscience) and analyzed
using FlowJo software.
Etaa1 cDNA Analysis. RNA was isolated from 2 × 106 total Etaa1+/+ or
Etaa1ΔEx2/ΔEx2 splenocytes using the Qiagen RNeasy Kit, and cDNA was syn-
thesized with the Invitrogen SuperScript III Reverse-Transcriptase Kit. PCR
was then performed using Taq polymerase (Invitrogen) with 1.5 mM MgCl2,
10% DMSO, and 0.5 μM each of the following primers: forward (exon
1 binding), 5′-AAGGAAGCATGCGGACAG-3′; reverse (exon 5 binding).
5′-TTGGATCACATCAAGTTCTTCC-3′. PCR cycling conditions were as follows:
94 °C for 3 min and then 35 cycles of 94 °C for 45 s, 56 °C for 30 s, 72 °C for
90 s, and then 72 °C for 10 min. Bands were cut out and the DNA was
isolated using a Qiagen Gel Extraction Kit before submission for Sanger
sequencing (using the aforementioned primers) at the Biomolecular Re-
source Facility of the John Curtin School of Medical Research, Australian
National University.
In Vitro T-Cell Stimulation and Division Analysis. CTV (Life Technologies) la-
beling was performed using a final CTV concentration of 10 μM as described
previously (44). For anti-CD3/CD28 stimulation, CTV-labeled CD45.1+ Etaa1+/+
and CD45.2+ Etaa1ΔEx2/ΔEx2 splenocytes were mixed in a 50:50 ratio, and 5 × 105
cells/well were stimulated in 0.1–10 μg/mL soluble anti-CD3 (clone 500A2; BD
Biosciences) with or without 2 μg/mL anti-CD28 (clone 37.15; BD Biosciences) in
a flat-bottom 96-well plate. For in vitro P14 stimulation, 2 × 106 P14 total
splenocytes per well were cultured in a flat-bottom 24-well plate with 10 ng/mL
LCMV GP33–41 peptide (Biomolecular Resource Facility of the John Curtin School
of Medical Research, Australian National University) and 10 ng/mL recombinant
human IL-2 (Peprotech). Daily cell counts were normalized via expression as fold
change over the starting number of CD8+Vα2+ P14 cells.
Transfection and Western Blot Analysis. Mouse Etaa1 was amplified from a
mouse spleen cDNA pool with Platinum Pfx DNA Polymerase (Thermo Fisher
Scientific). The coding sequence of Etaa1 was cloned into the pcDNA3.1+
mammalian expression vector using the BamHI/XhoI sites, with the resulting
clone confirmed using Sanger sequencing. For the GFP fusion protein, the
Etaa1 sequence lacking the first methionine was cloned into a pcDNA3.1+
vector containing the GFP gene to generate a fusion protein. The ΔEx2
mutant Etaa1 sequence was generated with site-directed mutagenesis using
primers that joined the first and third exons. HEK293T cells were transfected
with pcDNA3.1+ vectors expressing GFP-fused wild-type and ΔEx2 Etaa1 us-
ing Lipofectamine 3000 (Thermo Fisher Scientific). Cells were harvested and
lysed with sample buffer at 48 h after the transfection. Proteins were frac-
tionated using a 4–15% Mini-PROTEAN TGX precast gel (Bio-Rad). Etaa1 and
β-actin were probed with anti-GFP and anti–β-actin antibodies (GF28R, from
eBioscience, and AC-15, from Sigma-Aldrich).
Bone Marrow Chimeras. Rag1−/− recipient mice were irradiated with 5 Gy
and then reconstituted with 2 × 106 bone marrow cells consisting of a
50:50 mixture of wild-type B6.CD45.1+ bone marrow and B6.CD45.2+ Etaa1+/+
or Etaa1ΔEx2/ΔEx2 bone marrow. Mice were allowed to reconstitute for at least
8 wk before use in experiments. To account for reconstitution differences
between Etaa1+/+ or Etaa1ΔEx2/ΔEx2 bone marrow, the %CD45.2+ cells in a
given lymphocyte subset measured after immunization or infection was
normalized to the %CD45.2+ cells in the parent subset measured in the same
chimeric mouse before immunization or infection. Using LCMV tetramer-
positive CD8+ T cells as an example, the %CD45.2+ cells in the tetramer-
positive CD8+ T-cell subset measured after infection was divided by the
%CD45.2+ cells in all CD8+ T cells measured in the same mouse bled before
infection, and then multiplied by 100 and divided by 2 to set the pre-
infection %CD45.2+ at 50%.
RNA-seq Analysis. For RNA-seq analysis, 5 ×104 CD45.1+ Etaa1+/+ or Etaa1ΔEx2/ΔEx2
P14 cells were transferred into wild-type (CD45.2+) C57BL/6 mice, followed by
LCMV-Arm infection. At day 5 postinfection, CD8+ CD45.1+ P14 cells were
isolated by fluorescence activated cell sorting, with four separate sorts con-
ducted per genotype (i.e., eight samples total), and ∼5 × 105–1 × 106 cells were
recovered per sort. Total RNA was isolated using the Qiagen RNeasy Kit, and
RNA-seq libraries were prepared at the Biomolecular Resource Facility, John
Curtin School of Medical Research, Australian National University using the
Illumina TruSeq Stranded mRNA Library Prep Kit. Samples were sequenced on
an Illumina HiSeq 2500 instrument. All reads were aligned to the mouse ge-
nome reference sequence (GRCm38) using HiSat2 (45) with default
parameters. Read counts were then generated for each gene in each sample
using FeatureCounts (46), using annotated gene locations. Differential
expression analysis was performed using edgeR (28) using a Benjamini–
Hochberg adjusted P value threshold of 0.05 to identify significantly differ-
entially regulated genes. GO, KEGG, and transcription factor (TF) motif
enrichment analyses were performed using g:Profiler (30) based on the set
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of significantly differently regulated genes identified above. GSEA (29) was con-
ducted by searching the ranked wild-type vs. mutant RNA-seq dataset against the
Hallmark Gene Sets within MSigDB using the GSEA desktop application.
Statistics. Graphs and statistical analyses were generated using Prism version
7.0 (GraphPad Software). P values were calculated using the two-tailed un-
paired t test, or the two-tailed Mann–Whitney U test when data failed
normality tests. For multiple comparisons (Fig. 1G), one-way ANOVA with a
Tukey posttest was used, whereas two-way ANOVA was used in Fig. 6A. For
Table 1, a χ2 test was conducted to compare observed and expected
genotype ratios.
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Table S1. Genes differentially expressed in Etaa1ΔEx2/ΔEx2 vs.
Etaa1+/+ P14 cells at day 5 postinfection
logFC logCPM P value FDR MGI symbol
5.50 0.32 3.19E-41 6.62E-38 Zfp750
5.26 0.98 2.68E-48 8.33E-45 Tnfsf4
4.15 1.28 1.08E-43 2.51E-40 Plk2
4.08 0.40 6.45E-30 7.07E-27 Ak1
4.07 2.66 7.23E-108 6.74E-104 Phlda3
3.81 1.64 1.45E-09 1.80E-07 Hspa1b
3.69 4.84 0.00E+00 0.00E+00 Serpine2
3.41 1.07 3.06E-34 4.07E-31 Zak
3.21 1.24 3.23E-11 5.73E-09 Tcrg-C4
2.61 0.92 4.28E-08 3.51E-06 Trgv2
2.46 1.12 7.63E-16 2.79E-13 Trim66
2.33 1.59 3.04E-14 9.28E-12 Batf3
2.32 0.52 1.60E-07 1.14E-05 Tcrg-C1
2.28 0.33 2.86E-09 3.42E-07 Eng
2.25 2.75 3.11E-40 5.80E-37 Fam212b
2.25 2.81 3.60E-32 4.20E-29 Bbc3
2.19 0.44 2.75E-05 1.00E-03 Capn11
2.19 2.82 5.67E-08 4.46E-06 Tcrg-C2
2.11 2.79 2.16E-07 1.47E-05 Fos
2.00 2.28 9.31E-09 9.39E-07 Xcl1
2.00 0.11 3.74E-12 7.58E-10 Ahnak2
1.93 0.22 1.19E-11 2.21E-09 Prrg4
1.90 1.91 1.74E-20 1.08E-17 Tnfsf8
1.88 0.80 1.42E-05 5.78E-04 Trbv29
1.85 1.40 4.78E-15 1.59E-12 Nos1
1.85 5.99 5.13E-59 2.39E-55 Cdkn1a
1.85 3.40 4.10E-14 1.17E-11 Jun
1.79 0.79 3.11E-10 4.36E-08 D630045J12Rik
1.77 2.67 3.30E-32 4.10E-29 Zfp365
1.75 1.86 9.20E-17 3.83E-14 Cd81
1.72 3.35 5.15E-13 1.20E-10 Lrp1
1.71 4.25 1.51E-38 2.16E-35 9030617O03Rik
1.71 0.93 1.74E-10 2.61E-08 Zfp385a
1.68 1.76 2.61E-10 3.80E-08 Fosb
1.67 0.09 2.42E-05 9.05E-04 mt-Tc
1.63 0.71 5.03E-05 1.64E-03 Trbv1
1.61 3.95 4.61E-47 1.23E-43 Psrc1
1.56 0.94 2.67E-07 1.77E-05 5830418P13Rik
1.54 0.67 5.91E-09 6.45E-07 Sdc1
1.52 0.69 3.78E-03 4.68E-02 Trbv13-1
1.52 3.06 9.23E-25 8.19E-22 Maats1
1.49 0.76 1.17E-07 8.64E-06 Mcam
1.48 0.42 8.76E-06 3.77E-04 Mx2
1.47 0.69 6.37E-06 2.87E-04 Gm10382
1.47 1.98 1.06E-11 2.02E-09 Dclk1
1.44 1.64 1.15E-12 2.46E-10 Ephx1
1.42 2.98 3.92E-08 3.29E-06 Tnfrsf10b
1.41 0.73 1.00E-06 5.82E-05 Cox6b2
1.40 7.66 6.80E-05 2.06E-03 Gm43549
1.39 3.59 9.24E-17 3.83E-14 Rgs16
1.37 1.44 1.20E-05 4.98E-04 Egr2
1.37 7.59 3.78E-104 2.35E-100 Ccng1
1.36 3.26 7.21E-16 2.69E-13 Cd80
1.35 2.57 1.59E-16 6.18E-14 Perp
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1.34 0.48 6.43E-05 1.97E-03 Bmpr1a
1.33 0.94 1.20E-03 2.05E-02 Trbv16
1.32 4.43 1.04E-05 4.37E-04 Ccl3
1.30 2.40 3.95E-12 7.84E-10 Tnfrsf4
1.29 1.34 3.06E-07 2.00E-05 Utf1
1.28 0.55 2.37E-04 5.77E-03 Trbv20
1.26 4.81 2.45E-49 9.16E-46 Zmat3
1.25 2.12 4.06E-14 1.17E-11 Dcxr
1.25 0.32 5.08E-05 1.66E-03 Gm9522
1.23 3.46 8.46E-23 6.57E-20 Snhg15
1.23 0.41 3.70E-06 1.80E-04 Ogdhl
1.23 1.80 5.88E-04 1.16E-02 Trbv13-2
1.17 0.02 1.50E-04 4.02E-03 Spint1
1.16 0.01 2.30E-03 3.26E-02 Bst1
1.16 0.47 1.75E-05 6.89E-04 Etv4
1.16 4.45 1.10E-04 3.11E-03 Ccl4
1.15 0.36 1.14E-03 1.98E-02 Tctex1d2
1.15 0.62 3.16E-05 1.11E-03 Slc4a11
1.14 1.24 7.19E-06 3.19E-04 Irak1bp1
1.13 1.39 3.35E-08 2.86E-06 Map7
1.13 0.11 1.70E-03 2.60E-02 Hectd2
1.13 3.57 4.36E-20 2.62E-17 Slc19a2
1.10 0.32 4.87E-04 9.95E-03 Rasal2
1.10 4.33 1.52E-12 3.18E-10 Tnfrsf8
1.08 1.98 7.46E-07 4.49E-05 Filip1
1.07 3.06 4.07E-11 7.03E-09 Nebl
1.07 5.71 2.17E-24 1.84E-21 Mx1
1.07 1.08 6.94E-04 1.32E-02 Siglec1
1.07 0.58 5.86E-05 1.84E-03 Gm10451
1.06 0.07 2.60E-04 6.22E-03 Cdc42bpb
1.05 0.24 1.53E-03 2.44E-02 Snord83b
1.05 5.59 9.62E-16 3.45E-13 Trp53inp1
1.04 1.29 4.85E-06 2.25E-04 S100a3
1.04 1.47 2.35E-06 1.25E-04 Cd200
1.04 5.27 4.77E-05 1.57E-03 Ifng
1.04 1.43 3.56E-03 4.47E-02 Egr3
1.04 1.89 2.24E-06 1.19E-04 Slc29a2
1.03 3.82 3.94E-06 1.90E-04 Nr4a3
1.03 0.88 3.47E-04 7.75E-03 Acsl3
1.01 3.17 1.70E-13 4.35E-11 Plxna1
−1.01 0.45 5.55E-04 1.11E-02 Enho
−1.02 4.20 4.89E-08 3.95E-06 Tppp3
−1.13 1.83 4.90E-08 3.95E-06 Crybb1
−1.24 0.33 1.74E-04 4.52E-03 Gm4208
−1.27 3.17 6.09E-13 1.35E-10 Epha8
−1.28 2.40 9.25E-11 1.51E-08 Srcin1
−1.31 0.41 7.65E-04 1.42E-02 Gm37829
−1.33 0.36 8.59E-07 5.07E-05 Gm11611
−1.34 0.14 4.47E-05 1.49E-03 Rsph10b
−1.41 2.35 1.49E-07 1.06E-05 Ablim2
−1.43 3.79 1.80E-21 1.20E-18 S1pr5
−1.57 0.05 3.62E-05 1.25E-03 Gm38102
−1.57 2.39 3.83E-09 4.38E-07 Mir142hg
−1.60 5.93 1.21E-21 8.71E-19 Cx3cr1
−2.70 0.79 1.31E-10 2.07E-08 Plagl1
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Table S2. TF-binding motifs enriched in genes up-regulated within Etaa1ΔEx2/ΔEx2 P14 cells
TF-binding motif Motif ID P value
Factor: p53; motif: RGRCWWGYCYNGRCWWGYYY; match class: 0 TF:M01652_0 1.85E-08
Factor: p53; motif: RGRCWWGYCYNGRCWWGYYY; match class: 1 TF:M01652_1 4.95E-08
Factor: p53; motif: GGACATGCCCGGGCATGTCY; match class: 0 TF:M00034_0 0.00000104
Factor: P53; motif: RGRCATGYCYRGRCATGYYY; match class: 1 TF:M01651_1 0.00000604
Factor: P53; motif: RGRCATGYCYRGRCATGYYY; match class: 0 TF:M01651_0 0.00000619
Factor: p53; motif: GGACATGCCCGGGCATGTCY; match class: 1 TF:M00034_1 0.00000952
Factor: P53; motif: NNNNNACAWGCCYNNN; match class: 0 TF:M07054_0 0.00000999
Factor: BCL6B; motif: NNNNCCGCCCCWNNNN; match class: 1 TF:M02844_1 0.00493
Factor: P53; motif: NNNNNACAWGCCYNNN; match class: 1 TF:M07054_1 0.00993
Factor: BTEB2; motif: RGGGNGKGGN; match class: 1 TF:M07277_1 0.0131
Factor: AHR; motif: CACGCN; match class: 1 TF:M01855_1 0.0197
Factor: BEN; motif: CAGCGRNV; match class: 1 TF:M01240_1 0.0225
Factor: AP-4; motif: RNCAGCTGC; match class: 0 TF:M00927_0 0.0256
Factor: HTF4; motif: RACAGCTGNNN; match class: 0 TF:M07134_0 0.0303
Other Supporting Information Files
SI Appendix (PDF)
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APPENDIX 1. Full histopathology report from three Etaa1+/+ and three 
Etaa1ΔEx2/ΔEx2 female mice (62 weeks of age)  
Contacts:
Tina Cardamone, Manager APN
(Melbourne)
Louise Pontell, Research Histologist
Professor Janet Keast, Head APN
(Melbourne)
Australian Phenomics Network
Histopathology and Organ Pathology
The University of Melbourne
Department of Anatomy and Neuroscience
Grattan Street, PARKVILLE, VIC 3010
T: +61 3 83448044 F: +61 3 93479619
apn-info@unimelb.edu.au
9.1 Histopathology Report
Case Number APN16/042 The John Curtin School of Medical Research, The Australian
National University (Lisa Miosge)
Registration Date Tue 06/12/2016
Animal Details ENU28 11 G7#338, WT
DOB: 29/09/15 & 02/10/15, 62 weeks, Female, 27.5g, Black
Strain: C57Bl/6 Ncrl
ENU28 11 G7#340, WT
DOB: 29/09/15 & 02/10/15, 62 weeks, Female, 30.8g, Black
Strain: C57Bl/6 Ncrl
ENU28 11 G7#345, WT
DOB: 29/09/15 & 02/10/15, 62 weeks, Female, 36.0g, Black
Strain: C57Bl/6 Ncrl
ENU28 11 G7#355, Homozygous
DOB: 29/09/15 & 02/10/15, 62 weeks, Female, 26.9g, Black
Strain: C57Bl/6 Ncrl
ENU28 11 G7#359, Homozygous
DOB: 29/09/15 & 02/10/15, 62 weeks, Female, 27.0g, Black
Strain: C57Bl/6 Ncrl
ENU28 11 G7#360, Homozygous
DOB: 29/09/15 & 02/10/15, 62 weeks, Female, 19.8g, Black
Strain: C57Bl/6 Ncrl
DoD / Necropsy Wed 07/12/2016
Death CO2
Origin The John Curtin School of Medical Research, The Australian National
University
Treatment ENU
ENU induced mutation in a gene suspected to be involved in DNA repair (L.
Miosge).
Species / Breed / Strain
Animal Health Facility Australian Phenomics Facility, ANU
POSITIVE for Staphylococcus aureus
POSITIVE for Entamoeba muris
POSITIVE for Tritrichomonas muris
POSITIVE for Pasteurellaceae spp (not including pneumotropica)
POSITIVE for Pasteurella pneumotropica
POSITIVE for Helicobacter spp
POSITIVE for Mouse Norovirus
POSITIVE for Chilomastix bettencourti
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Organs Examined Adrenal glands, Bladder, Bone marrow, Brain, Cecum, Cervix, Clitoral gland,
Colon, Duodenum, Eyes, Gall bladder, Harderian glands, Head, Heart, Hind
leg (Long bone, Bone marrow, Synovial joint, Skeletal muscle), Ileum,
Jejunum, Kidney, Liver, Lungs, Mammary tissue, Mesenteric lymph node,
Other tissue, Ovaries, Oviducts, Pancreas, Salivary glands and Regional
lymph nodes, Skin, Spinal cord, Spleen, Stomach, Tail, Thymus, Thyroids,
Trachea, Uterus, Vagina
Macroscopic
Observations
Date of transport to the APN: Wednesday 7th December
Time animal/tissue dispatched: 2:30pm Tuesday 6th December
Courier/Transportation details: Jetpets
At the time of necropsy, the animals appeared well nourished, well groomed,
active/curious and healthy with normal movement and gait. There were no
observable dermal lesions and no nasal/ocular discharges.
Animal #340 showed excessive abdominal fat around the reproductive
organs as well as a pale tan lesion running along the ascending portion of its
colon measuring 25x10x5mm. #338 also showed some excessive fat around
the reproductive organs and #359 had an enlarged spleen.
The gastrointestinal tracts of the remaining animals contained ample ingesta
and the thoracic and abdominal viscera showed no macroscopic
abnormalities.
Microscopic Observations
Blood Report:
Most most readings were within the normal mouse reference intervals.
The platelet count for ENU28 11 G7#355 & ENU28 11 G7#360 was low, but as the MPV was within range,
this is likely to not be significant. Decreased platelets are common haematologic finding in mice. However
this change is often secondary to blood collection difficulties rather than a true decrease in platelet counts.
Mouse platelets readily aggregate and instrument generated platelet counts will underestimate true
platelet counts in the presence of platelet clumping.
The eosinophil count for all animals was elevated, this is a common occurrence in mice.
The following micromorphological changes observed in the knock-outs were also observed in the control
animals #338, #340 and #345.
Ceroid-lipofuscin laden cells in the ovaries: #338, #340 and #345
Cystic oviducts: #338, #340 and #345
Cystic endometrial hyperplasia of the uterus: #340 and #345
Inflammatory aggregates within the urinary bladder: #338 and #345
Inflammatory infiltrates within the liver: #340
Inflammatory infiltrates within various organs (including pancreas, kidneys, salivary glands, lungs and
Harderian glands): #338, #340 and #345
Basophilic valvular changes in the heart: #340 and #345
Reduction in density of spiral ganglion cells: #340
Note:
(i) Reactive lymph nodes are defined as mild follicular hyperplasia, germinal centre formation and
occasional sinus histiocytosis - a common finding in mice
(ii) Mild extramedullary hematopoiesis (EMH) identified in the red pulp of all the spleens, a common
finding in the mouse. EMH consists of erythroid precursors, myeloid precursors, megakaryocytes or all
three. While some degree of extramedullary hematopoiesis is present in normal rodents, especially in
mice, increased extramedullary hematopoiesis can result from hematotoxic insult, systemic anemia, and
infections elsewhere in the body. A.W Suttie, 2006
(iii) Focal inflammatory cell aggregates consisting of mononuclear, polymorphonuclear, and/or histiocytic
cells are frequently observed in ageing mice (R. R. Maranport). These can be present as lymphoid
aggregates found in various tissues including the renal pelvis, bladder, lungs, liver (C. Pettan-Brewer and
P. M. Treuting “Practical pathology of aging mice”) and salivary glands (M. R. Anver and D.C. Haines “ the
Fri, 17 Feb 2017 11:22:18 AM APN16/042 | Page 2 of 25
Laboratory Mouse”).
(iv) Intracellular eosinophilic crystals may occasionally be seen in the lungs of mice. It has been reported
that these structures may represent eosinophil granules at various stages of degradation (Murray and Luz,
1990). Others believe the crystals may represent haemoglobin breakdown following uptake by
macrophages (Shultz et al., 1984).
Summary KO animals:
#355
Ovaries: ceroid-lipofuscin laden cells (58992, 59365)
Oviducts: Query - appear cystic (58992, 59365)
Uterus: cystic endometrial hyperplasia (58992, 59365)
Urinary bladder: inflammatory aggregate (59365)
Liver: inflammatory infiltrates (58990)
Kidneys: inflammation, tubular degeneration protein casts. Query: loss of typical nodal architecture of
renal lymph nodes (58991, 59367)
Salivary glands: inflammatory infiltrates (58987). Query: one lymph node displays a loss of typical
reactive architecture (59366)
Lungs: inflammatory infiltrates (58996, 59368)
Heart: basophilic valvular changes (58985)
#359
Mammary glands: inflammatory aggregate (58963)
Ovaries: ceroid-lipofuscin laden cells (58964, 59371, 59372)
Oviducts: Query - appear cystic (58964, 59371, 59372)
Uterus: cystic endometrial hyperplasia (58964, 59371, 59372), inflammatory infiltrates (59371)
Liver: inflammatory infiltrates (58962)
Stomach: inflammatory infiltrates (58968)
Kidneys: inflammatory infiltrates and protein casts (58953, 59369)
Salivary glands: inflammatory infiltrates and lipofucsin laden cells (58965, 59370)
Lungs: inflammatory infiltrates and eosinophilic crystals (58966)
Thymus: cyst-like structure (58967)
Heart: basophilic valvular changes (58950)
Harderian glands: inflammatory aggregate (58957)
#360
Ovaries: ceroid-lipofuscin laden cells (59374, 59375)
Oviducts: Query - appears cystic (59374, 59375)
Uterus: cystic endometrial hyperplasia (58929, 59374, 59375)
Vagina: inflammatory infiltrates (59375)
Urinary bladder: inflammatory aggregate (59374)
Liver: inflammatory infiltrates (58934)
Pancreas: inflammatory infiltrates (58924, 58940)
Kidneys: inflammatory infiltrates and protein casts (58935, 59373)
Salivary glands: inflammatory infiltrates (58926)
Lungs: inflammatory infiltrates (58931)
Heart: Query - degenerating myocytes (58938)
Harderian gland: inflammatory aggregate (58939)
Summary WT animals:
#338
Ovaries: ceroid-lipofuscin laden cells (59063, 59358)
Oviducts: Query - appears cystic (59063, 59358)
Urinary Bladder: inflammatory aggregates (59063, 59358)
Pancreas: inflammatory infiltrates (59071, 59075)
Kidneys: inflammatory infiltrates and protein casts (59066, 59360)
Salivary glands: inflammatory infiltrates (59062, 59359)
Lungs: inflammatory infiltrates (59081)
Heart: basophilic valvular changes (59069)
Skin: inflammatory infiltrates (59076)
Harderian gland: inflammatory infiltrates (59070)
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#340
Mammary glands: inflammation (59038)
Ovaries: ceroid-lipofuscin laden cells (59039, 59361)
Oviducts: Query - appears cystic (59039, 59361)
Uterus: cystic endometrial hyperplasia (59039, 59361)
Liver: inflammatory infiltrates (59036, 59037)
Colon: lymphoid lesion (59051)
Pancreas: inflammatory infiltrates (59042, 59045)
Kindeys: protein cast (59036)
Salivary glands: inflammatory infiltrates (59040)
Lungs: inflammation and haemorrhage (59047, 59362)
Heart: basophilic valvular changes (59052)
Head: reduction in density of spiral ganglion cells (59058)
#345
Ovaries: ceroid-lipofuscin laden cells (59025, 59363)
Oviducts: Query - appears cystic? (59025, 59363)
Uterus: cystic endometrial hyperplasia (59025, 59363)
Urinary bladder: inflammatory aggregate (59363)
Pancreas: inflammatory infiltrates (59006, 59017, 59022)
Kidneys: inflammatory infiltrates (59364)
Salivary glands: inflammatory infiltrates and query: loss of typical nodal architecture (59024).
Lungs: inflammatory infiltrates (59010)
Heart: basophilic valvular changes (59015)
Harderian glands: inflammatory infiltrates (59016)
ENU28 11 G7#338 (control)
Macro Observations
Spleen: 14x4x2mm,
Kidneys: 12x7x6mm, symmetrical
Thymus: 9x6x2mm
Heart: 9x6x5mm
Brain: 14x10x5mm, symmetrical
Pituitary gland identified, macroscopically normal
Tail 82mm (straight)
Teeth, tongue and oral mucosa unremarkable - Head harvested for evaluation of auditory and
vestibular structures
Tail suspension test for neurological defects-negative
Excessive fat (+) around reproductive organs
Micro Observations
Marrow smear: Examination of the smear showed representative cells from the myeloid and
erythroid series. Conspicuous cells from the lymphoid series. Numerous and unremarkable
megakaryoblasts.
(59089)
Peripheral blood smear: Examination of the smear showed red blood cells (majority of cells
shown), occasional white blood cells including lymphocytes, segmented neutrophils, platelets
(clumps) and monocytes. No discernible morphological changes or detectable parasites.
(59088)
Ovaries: Moderate interstitial age related ceroid-lipofuscin laden cells (59063, 59358)
Oviducts: Query - portions of serosa appear mildly cystic (59063, 59358)
Pathology to comment
Urinary Bladder: Moderate multifocal submucosal lymphocytic aggregates (59063, 59358)
Pancreas: Mild multifocal perivascular lymphocytic infiltrates (59071, 59075)
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Kidneys: In both kidneys - mild multifocal perivascular lymphocytic infiltrates mainly adjacent or
near renal cavity. Several protein casts within medulla and papilla (59066, 59360)
Salivary glands: Mild to moderate multifocal perivascular lymphocytic infiltrates within the
submandibular and sublingual glands (59062, 59359)
Lungs: Mild focal perivascular lymphocytic infiltrates (59081)
Heart: Mild basophilic valvular changes, likely to be age related (59069)
Skin: Mild focal lymphocytic infiltrates within the subcutis (59076)
Harderian gland: Mild focal perivascular lymphocytic infiltrates (59070)
ENU28 11 G7#340 (control)
Macro Observations
Spleen: 20x8x2mm
Kidneys: 10x6x5mm, symmetrical
Thymus: 7x7x2mm
Heart: 10x6x5mm
Brain: 15x10x5mm, symmetrical
Pituitary gland identified, macroscopically normal
Tail 85mm (straight)
Teeth, tongue and oral mucosa unremarkable - Head harvested for evaluation of auditory and
vestibular structures
Tail suspension test for neurological defects-negative
Excessive fat (+++) around reproductive organs.
Pale tan lesion 25x10x5mm running along the ascending colon.
Micro Observations
Marrow smear: Examination of the smear showed representative cells from the myeloid and
erythroid series. Conspicuous cells from the lymphoid series. Numerous and unremarkable
megakaryoblasts.
(59061)
Peripheral blood smear: Examination of the smear showed red blood cells (majority of cells
shown), occasional white blood cells including lymphocytes, segmented neutrophils, platelets
(clumps) and monocytes. No discernible morphological changes or detectable parasites.
(59060)
Mammary glands: Mild focal lymphocytic aggregate adjacent to a subcutical nerve fascicle
(59038)
Ovaries: Moderate to severe interstitial age related ceroid-lipofuscin laden cells (59039, 59361)
Oviducts: Query - portions of serosa appear mildly cystic (59039, 59361)
Uterus: Mild cystic endometrial hyperplasia, a common age related lesion (59039, 59361)
Liver: Moderate multifocal perivascular lymphocytic infiltrates (59037)
Colon: Well circumscribed large lymphoid lesion consisting of large polymorphhic lymphoid cells
that are non impinging on the colon (59051)
Pathology to comment
Pancreas: Mild multifocal perivascular lymphocytic infiltrates (59042, 59045)
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Kindey: Single short protein cast within medulla (59036)
Salivary glands: Mild multifocal perivascular lymphocytic infiltrates within the submandibular and
sublingual glands (59040)
Lungs: Moderate multifocal perivascular inflammation, moderate multifocal haemorrhage and
some areas of varying degrees of congestion and atelectasis (59047, 59362)
Pathology to comment
Heart: Mild basophilic valvular changes, likely to be age related (59052).
Head: Reduction in density of the spiral ganglion cells, a common age related feature (59058)
ENU28 11 G7#345 (control)
Macro Observations
Spleen: 16x4x3mm
Kidneys: 10x6x5mm, symmetrical
Thymus: 10x5x2mm
Heart: 8x5x5mm
Brain: 13x10x6mm, symmetrical
Pituitary gland identified, macroscopically normal
Tail 80mm (straight)
Teeth, tongue and oral mucosa unremarkable - Head harvested for evaluation of auditory and
vestibular structures
Tail suspension test for neurological defects-negative
Micro Observations
Marrow smear: Examination of the smear showed representative cells from the myeloid and
erythroid series. Conspicuous cells from the lymphoid series. Numerous and unremarkable
megakaryoblasts.
(59032)
Peripheral blood smear: Examination of the smear showed red blood cells (majority of cells
shown), occasional white blood cells including lymphocytes, segmented neutrophils, platelets
(clumps) and monocytes. No discernible morphological changes or detectable parasites.
(59033)
Ovaries: Mild to moderate interstitial age related ceroid-lipofuscin laden cells (59025, 59363)
Oviducts: Query - portions of serosa appear mildly cystic (59025, 59363)
Uterus: Mild cystic endometrial hyperplasia, a common age related lesion (59025, 59363)
Urinary bladder: Mild focal submucosal lymphocytic aggregate (59363)
Pancreas: Mild multifocal perivascular lymphocytic infiltrates (59006, 59017, 59022)
Kidney: Mild focal perivascular lymphocytic infiltrates (59364)
Salivary glands: Mild to moderate perivascular lymphocytic infiltrates. Query - loss of typical
nodal architecture of the regional lymph nodes (59024)
Pathology to comment
Lung: Mild focal perivascular/peribronchial lymphocytic infiltrates (59010)
Heart: Mild basophilic valvular changes, likely to be age related (59015)
Harderian glands: Mild multifocal perivascular lymphocytic infiltrates (59016)
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ENU28 11 G7#355
Macro Observations
Spleen: 15x4x2mm
Kidneys: 12x5x5mm, symmetrical
Thymus: 6x5x2mm
Heart: 10x6x5mm
Brain: 14x10x5mm, symmetrical
Pituitary gland identified, macroscopically normal
Tail 80mm (straight)
Teeth, tongue and oral mucosa unremarkable - Head harvested for evaluation of auditory and
vestibular structures
Tail suspension test for neurological defects-negative
Micro Observations
Marrow smear: Examination of the smear showed representative cells from the myeloid and
erythroid series. Conspicuous cells from the lymphoid series. Occassional and unremarkable
megakaryoblasts.
(59004)
Peripheral blood smear: Examination of the smear showed red blood cells (majority of cells
shown), occasional white blood cells including lymphocytes, segmented neutrophils, platelets
(clumps) and monocytes. No discernible morphological changes or detectable parasites.
(59005)
Mammary glands
Section shows typical mammary fat pad with developing lactiferous ducts, blood vessels and
nerve bundles. Some scattered mast cells identified; a common finding in mouse mammary
tissue.
(58993)
No lesions of significance
Ovaries/Oviducts
Section shows ovaries containing follicles at various stages of development (primary through to
antral), several corpora lutea and mild to moderate interstitial age related ceroid-lipofuscin laden
cells.
Unremarkable oviduct micromorphology with typical columnar epithelium and mucosal folds.
Query - portions of serosa appear mildy cystic.
(58992, 59365)
Comments:
Pathology to comment
Uterus/Cervix/Vagina/Clitoral gland
The architecture of the endometrium/endometrial glands, myometrium and adventitia are
discernible.
Sections show mild cystic endometrial hyperplasia, a common age related lesion.
Some neutrophils and low numbers of lymphocytes identified in the endometrial glands; a
common finding within a non-inflamed endometrium during the phases of estrus.
The micromorphology of the uterus and vagina places the animal at metestrus.
(58992, 59365)
Urinary Bladder
Distended bladder with discernible urothelium and detrusor muscle.
Sections show a mild focal perivascular lymphocytic aggregate within the submucosa (59365).
Sections also include unremarkable ureter and urethra.
(58992, 59365)
Fri, 17 Feb 2017 11:22:18 AM APN16/042 | Page 7 of 25
Liver/Gall bladder
Section shows liver parenchyma including hepatocytes, Kupffer cells, portal triads and central
veins.
Section also shows mild focal perivascular and parenchymal lymphocytic aggregate.
Unremarkable Gall bladder.
(58990)
Comments:
Pathology to comment
Stomach
Section shows unremarkable fore and glandular portions of the stomach with limiting ridge.
Section also includes pylorus sphincter and duodenal bulb.
(58994)
No lesions of significance
Small Intestine (Duodenum, Jejunum & Ileum)/GALT
Section shows typical mucosal villi and submucosal layers.
Peyer’s patches displayed typical reactive nodal histology.
(58979, 58983)
No lesions of significance
Cecum/Colon/GALT
Typical mucosal folds and submucosal layers and occasional lymphoid cluster (Peyer's patch)
(58978, 58981)
No lesions of significance
Mesenteric lymph node
Section does not include mesenteric lymph node.
Spleen
Mild follicular hyperplasia and germinal center formation in the white pulp.
Moderate extramedullary hematopoiesis and Hemosiderin laden macrophages identified in the
red pulp, a common finding in the mouse.
(58989)
No lesions of significance
Pancreas
Section shows representative exocrine tissue (serous acini) and endocrine tissue (islets of
Langerhans).
(58989)
No lesions of significance
Kidney
Section shows a cortex, medulla, and papilla. There is a uniform distribution of Glomeruli and
accompanying nephron components.
Mild multifocal pervascular inflammation, mild multifocal tubular degeneration and a few dilated
tubules within the cortex.
Scattered, and at times enlarged dilated protein casts identified mainly within the medulla and
papilla.
Query: loss of typical nodal architecture of renal lymph nodes.
(58991, 59367)
Comments:
Pathology to comment
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Adrenal glands
Section shows adrenal glands with typical cortex/medulla distribution.
A few age related lipofuscin laden cells at the cortical-medullary junction and mild subcapsular
spindle cell hyperplasia, a common background lesion.
(59367)
Salivary glands and Regional lymph nodes
Section shows submandibular gland with mild focal perivascular inflammation and unremarkable
sublingual and parotid glands (58987).
The regional lymph nodes displayed mild follicular hyperplasia with germinal centre formation,
indicating a reactive state.
Query: one lymph node displays a loss of typical reactive nodal architecture (59366).
(58987, 59366)
Comments:
Pathology to comment
Thyroids
Normal lateral lobes of the thyroid gland with typical colloid secreting follicles lined by cuboidal
epithelium.
(58996, 59368)
No lesions of significance
Trachea/Lungs
Section shows lung micromorphology demonstrating parenchyma/alveoli, bronchioles and blood
vessels with mild to moderate multifocal pericasvular/peribrochial lymphocytic infiltrates .
Trachea with unremarkable mucosal epithelial lining and hyaline cartilage.
Oesophagus with typical features including stratified squamous epithelium.
(58996, 59368)
Comments:
Pathology to comment
Thymus
Section shows typical medulla/cortex distribution and micromorphology.
(58997)
No lesions of significance
Heart/chambers/vessels/valves
Typical micromorphology observed in cardiac muscle, chambers, valves and vessels of the heart.
The cardiac muscle fibres demonstrated typical features including central nuclei, branching fibres
and striations.
Some mild basophilic valvular changes, likely to be age related.
(58985)
Comments:
Pathology to comment
Skin
Typical dermal appendages and distribution. Unremarkable thin layer of striated muscle
(panniculus carnosus).
(58986)
No lesions of significance
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Tail
Section shows typical tail components including keratinized squamous epithelium, dense regular
connective tissue, tendons, caudal vertebra, bone marrow, intervertebral disc, skeletal muscle,
nerves and blood vessels.
(58995)
No lesions of significance
Eyes/Harderian glands
Section shows eyes with unremarkable retina, cornea, iris, ciliary body, lens, sclera and choroid.
Typical branched tubuloalveolar formation of the Harderian gland.
Section also includes portion of unremarkable optic nerve and extraocular muscles.
(58984)
No lesions of significance
Brain
Sections were prepared from the standard levels of the brain:
Level I forebrain: including cortex, corpus callosum, caudate putamen and lateral ventricles
(Bregma 1.10mm)
Level II midbrain: including the hippocampus, thalamus, hypothalamus and lateral and third
ventricles (Bregma -1.46mm)
Level III hindbrain: includes the cerebellum, pons and fourth ventricle (Bregma -5.52mm)
Sections of brain stained with Haematoxylin and Eosin, Luxol Fast Blue appear symmetrical with
no ventricular dilation observed, unremarkable meninges and typical lamination.
The cerebellum appears symmetrical with typical architecture and Purkinje cells.
There was no evidence of neuronal loss and the myelination appeared normal.
(58980, 58998)
No lesions of significance
Comments:
Neuropatholoy to comment
Spinal cord
Representative thoracic and lumbar region of spinal cord, vertebral bone, striated muscle,
peripheral nerves and bone marrow.
(58988)
No lesions of significance
Comments:
Neuropatholoy to comment
(Hind leg) Long bone/Bone marrow/Synovial joint/Skeletal muscle
Section shows unremarkable long bone, striated muscle, synovial joint and bone marrow
including conspicuous megakaryoblasts. The skeletal muscle shows consistent fiber size with
peripheral nuclei.
(58982)
No lesions of significance
Head
Multiple levels through the head demonstrate dermal appendages, nasal cavity, oral cavity, teeth
and tongue including muscle bundles. Sections also show unremarkable pituitary gland including
pars intermedia, pars distalis and pars nervosa as well and the trigeminal nerve/ganglia (58999).
The outer and middle regions of the ear are discernible. The tympanic membrane is intact and
the ossicles are unremarkable and include the stapedial annular ligaments (59000-59003).
Typical components of the inner ear including bony labyrinth, organ of corti, stria vascularis and
scala cavities are discernible. Based on multiple levels, the organ of corti is unremarkable with no
discernible loss of inner/outer hair cells and typical tectorial membrane (59000-59003).
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The cochlear nerve and spiral ganglion is also demonstrated and based on several levels, there is
no reduction in the density of the spiral ganglion cells. Examples of otolith organs can be seen
with typical features such as the hair cells and mineral otoliths. The ampulla including the crista
ridge with hair cells is discernible (59000-59003).
No lesions of significance
(58999-59003)
ENU28 11 G7#359
Macro Observations
Spleen: 25x8x2mm, large
Kidneys: 12x7x6mm, symmetrical
Thymus: 7x7x2mm
Heart: 10x6x6mm
Brain: not measured, symmetrical
Pituitary gland identified, macroscopically normal
Tail 85mm (straight)
Teeth, tongue and oral mucosa unremarkable - Head harvested for evaluation of auditory and
vestibular structures
Tail suspension test for neurological defects-negative
Micro Observations
Marrow smear: Examination of the smear showed representative cells from the myeloid and
erythroid series. Conspicuous cells from the lymphoid series. Occassional and unremarkable
megakaryoblasts.
(58977)
Peripheral blood smear: Examination of the smear showed red blood cells (majority of cells
shown), occasional white blood cells including lymphocytes, segmented neutrophils, platelets
(clumps) and monocytes. No discernible morphological changes or detectable parasites.
(58976)
Mammary glands
Section shows mammary fat pad with developing lactiferous ducts, blood vessels, nerve bundles
and a lymph node with typical nodal histology.
Focal lymphocytic aggregate surrounding a single lactiferous duct.
Some scattered mast cells identified; a common finding in mouse mammary tissue.
(58963)
Ovaries/Oviducts
Section shows ovaries containing follicles at various stages of development (primary through to
antral), several corpora lutea and mild interstitial age related ceroid-lipofuscin laden cells.
Unremarkable oviduct micromorphology with typical columnar epithelium and mucosal folds.
Query - portions of serosa appear mildy cystic.
(58964, 59371, 59372)
Comments:
Pathology to comment
Uterus/Cervix/Vagina/Clitoral gland
The architecture of the endometrium/endometrial glands, myometrium and adventitia are
discernible.
Section shows mild cystic endometrial hyperplasia (58964, 59371, 59372), a common age
related lesion, and mild focal lymphocytic perivascular infiltrates within the myometrium
(59371).
Some neutrophils and low numbers of lymphocytes identified in the endometrial glands; a
common finding within a non-inflamed endometrium during the phases of estrus.
Fri, 17 Feb 2017 11:22:18 AM APN16/042 | Page 11 of 25
The micromorphology of the uterus and vagina places the animal at estrus.
(58964, 59371, 59372)
Urinary Bladder
Unremarkable collapsed bladder with typical urothelium and detrusor muscle.
Section includes unremarkable urethra.
(58964, 59371, 59372)
No lesions of significance
Liver/Gall bladder
Section shows liver parenchyma including hepatocytes, Kupffer cells, portal triads and central
veins with mild to moderate multifocal perivascular and parenchymal lymphocytic infiltrates.
Unremarkable Gall bladder.
(58962)
Comments:
Pathology to comment
Stomach
Section shows fore and glandular portions of the stomach with limiting ridge and mild focal
lymphocytic aggregates within the submucosa.
Section also includes pylorus sphincter and duodenal bulb.
(58968)
Small Intestine (Duodenum, Jejunum & Ileum)/GALT
Section shows typical mucosal villi and submucosal layers and occasional lymphoid cluster
(Peyer's patch)
(58952, 58956)
No lesions of significance
Cecum/Colon/GALT
Typical mucosal folds and submucosal layers and occasional lymphoid cluster (Peyer's patch).
Section includes pancreas with mild multifocal perivascular lymphocytic infiltrates (58955).
(58954, 58955).
Mesenteric lymph node
Section shows mesenteric lymph node with typical reactive micromorphology including mild
follicular hyperplasia, germinal centre formation and mild sinus histiocytosis.
(58965, 59370)
No lesions of significance
Spleen
Mild follicular hyperplasia of the white pulp.
Mild extramedullary hematopoiesis and Hemosiderin laden macrophages identified in the red
pulp of the spleen, a common finding in the mouse.
(58959)
No lesions of significance
Pancreas
Section shows representative exocrine tissue (serous acini) and endocrine tissue (islets of
Langerhans).
There is mild multifocal perivascular lymphocytic infiltrates in one section of the spleen (58955).
(58955, 58956, 58959)
Fri, 17 Feb 2017 11:22:18 AM APN16/042 | Page 12 of 25
Kidney
Section shows a cortex, medulla, and papilla. There is a uniform distribution of Glomeruli with
unremarkable micromorphology.
There are mild to moderate multifocal perivascular lymphocytic infiltrates (58953, 59369), a few
scattered short casts and one enlarged protein cast within the medulla (59369).
Section also includes renal lymph nodes with typical reactive nodal histology and mild sinus
histiocytosis.
(58953, 59369)
Comments:
Pathology to comment
Adrenal glands
Section shows adrenal glands with typical cortex/medulla micromorphology.
A few age related lipofuscin laden cells at the cortical-medullary junction and mild subcapsular
spindle cell hyperplasia, a common background lesion
(58953, 59369)
Salivary glands and Regional lymph nodes
Section shows unremarkable submandibular, sublingual and parotid glands.
Nearby associated glands shows mild multifocal lymphocytic aggregates, mild diffuse neutrophilic
infiltrates within the surrounding connective tissue and a few lipofucsin laden cells within the
gland. Associated glands are surrounded by connective tissue and axillary mammary glands.
The regional lymph nodes displayed mild follicular hyperplasia with germinal centre formation,
indicating a reactive state.
(58965, 59370)
Comments:
Pathology to comment
Thyroids
Unremarkable colloid secreting follicles identified. Section also shows a small sheet-like mass of
polygonal cells, characteristic of the parathyroid gland.
(58966)
No lesions of significance
Trachea/Lungs
Section shows lung micromorphology demonstrating parenchyma/alveoli, bronchioles, blood
vessels and parabronchial lymph node with mild to moderate multifocal perivascular lymphocytic
infiltrates.
Focal intracellular eosinophilic crystals within the cytoplasm of alveolar macrophages.
Trachea with unremarkable mucosal epithelial lining and hyaline cartilage.
Oesophagus with typical features including stratified squamous epithelium.
(58966)
Comments:
Pathology to comment
Thymus
Section shows typical medulla/cortex distribution and micromorphology.
Within the cortex, medium sized cyst like structure containing macrophages and cellular debris.
(58967)
Comments:
Pathology to comment
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Heart/chambers/vessels/valves
Typical micromorphology observed in cardiac muscle, chambers and vessels of the heart.
The cardiac muscle fibres demonstrated typical features including central nuclei, branching fibres
and striations.
Some mild basophilic valvular changes, likely to be age related.
(58950)
Comments:
Pathology to comment
Skin
Typical dermal appendages and distribution. Unremarkable thin layer of striated muscle
(panniculus carnosus).
(58958)
No lesions of significance
Tail
Section shows typical tail components including keratinized squamous epithelium, dense regular
connective tissue, tendons, caudal vertebra, bone marrow, intervertebral disc, skeletal muscle,
nerves and blood vessels.
(58961)
No lesions of significance
Eyes/Harderian glands
Section shows eyes with unremarkable retina, cornea, iris, ciliary body, lens, sclera and choroid.
Typical branched tubuloalveolar formation of the Harderian gland with a small focal lymphocytic
aggregate.
Section also includes portion of unremarkable optic nerve and extraocular muscles.
(58957)
Brain
Sections were prepared from the standard levels of the brain:
Level I forebrain: including cortex, corpus callosum, caudate putamen and lateral ventricles
(Bregma 0.50mm)
Level II midbrain: including the hippocampus, thalamus, hypothalamus and lateral and third
ventricles (Bregma -2.06mm)
Level III hindbrain: includes the cerebellum, pons and fourth ventricle (Bregma -5.80mm)
Sections of brain stained with Haematoxylin and Eosin, Luxol Fast Blue appear symmetrical with
no ventricular dilation observed, unremarkable meninges and typical lamination.
The cerebellum appears symmetrical with typical architecture and Purkinje cells.
There was no evidence of neuronal loss and the myelination appeared normal.
(58969, 58970)
No lesions of significance
Comments:
Neuropatholoy to comment
Spinal cord
Representative thoracic and lumbar region of spinal cord, vertebral bone, intervertebral disc,
striated muscle, peripheral nerves and bone marrow.
(58960)
No lesions of significance
Comments:
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Neuropatholoy to comment
(Hind leg) Long bone/Bone marrow/Synovial joint/Skeletal muscle
Section shows unremarkable long bone, striated muscle, synovial joint and bone marrow
including conspicuous megakaryoblasts. The skeletal muscle shows consistent fiber size with
peripheral nuclei.
(58951)
No lesions of significance
Head
Multiple levels through the head demonstrate dermal appendages, nasal cavity, oral cavity, teeth
and tongue including muscle bundles. Sections also show unremarkable pituitary gland including
pars intermedia, pars distalis and pars nervosa as well and the trigeminal nerve/ganglia (58971).
The outer and middle regions of the ear are discernible. The tympanic membrane is intact and
the ossicles are unremarkable and include the stapedial annular ligaments (58972, 58973).
Typical components of the inner ear including bony labyrinth, organ of corti, stria vascularis and
scala cavities are discernible. Based on multiple levels, the organ of corti is unremarkable with no
discernible loss of inner/outer hair cells and typical tectorial membrane (58972-58974).
The cochlear nerve and spiral ganglion is also demonstrated and based on several levels, there is
no reduction in the density of the spiral ganglion cells. Examples of otolith organs can be seen
with typical features such as the hair cells and mineral otoliths. The ampulla including the crista
ridge with hair cells is discernible (58972, 58974).
No lesions of significance
(58971-58974)
ENU28 11 G7#360
Macro Observations
Spleen: 14x4x2mm
Kidneys: 10x6x5mm, symmetrical
Thymus: 8x7x2mm
Heart: 10x6x5mm
Brain: 14x9x5mm, symmetrical
Pituitary gland identified, macroscopically normal
Tail 78mm (straight)
Teeth, tongue and oral mucosa unremarkable - Head harvested for evaluation of auditory and
vestibular structures
Tail suspension test for neurological defects-negative
Tissue presumed to be gall bladder - very dark brown/grey 3x2x2mm
Micro Observations
Marrow smear: Examination of the smear showed representative cells from the myeloid and
erythroid series. Conspicuous cells from the lymphoid series. Numerous and unremarkable
megakaryoblasts.
(58949)
Peripheral blood smear: Examination of the smear showed red blood cells (majority of cells
shown), occasional white blood cells including lymphocytes, segmented neutrophils, platelets
(clumps) and monocytes. No discernible morphological changes or detectable parasites.
(58948)
Mammary glands
Section shows typical mammary fat pad with developing lactiferous ducts, blood vessels and
nerve bundles. Some scattered mast cells identified; a common finding in mouse mammary
tissue.
(58928)
No lesions of significance
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Ovaries/Oviducts
Section shows ovaries containing follicles at various stages of development (primary through to
antral), several corpora lutea and mild interstitial age related ceroid-lipofuscin laden cells.
Unremarkable oviduct micromorphology with typical columnar epithelium and mucosal folds.
Query - portions of serosa appear mildy cystic.
(59374, 59375)
Comments:
Pathology to comment
Uterus/Cervix/Vagina/Clitoral gland
The architecture of the endometrium/endometrial glands, myometrium and adventitia are
discernible.
Moderate cystic endometrial hyperplasia (58929, 59374, 59375), a common age related lesion,
and mild focal lymphocytic perivascular infiltrates near the vagina (59375).
Some neutrophils and low numbers of lymphocytes identified in the endometrial glands; a
common finding within a non-inflamed endometrium during the phases of estrus.
The micromorphology of the uterus and vagina places the animal at metestrus.
(58929, 59374, 59375)
Urinary Bladder
Collapsed bladder with typical urothelium and detrusor muscle.
Mild focal lymphocytic aggregate within the submucosa (59374).
Section includes unremarkable urethra.
(58929, 59374, 59375)
Liver/Gall bladder
Section shows liver parenchyma including hepatocytes, Kupffer cells, portal triads and central
veins.
Mild multifocal periportal inflammatory aggregates (a common finding in the mouse) and mild
focal perivascular lymphocytic infiltrates.
Unremarkable Gall bladder.
(58934)
Stomach
Section shows unremarkable fore and glandular portions of the stomach with limiting ridge.
Section also includes pylorus sphincter and duodenal bulb.
(58923)
No lesions of significance
Small Intestine (Duodenum, Jejunum & Ileum)/GALT
Section shows typical mucosal villi and submucosal layers.
Peyer’s patches displayed typical reactive nodal histology.
(58936, 58940)
No lesions of significance
Cecum/Colon/GALT
Typical mucosal folds and submucosal layers and occasional lymphoid cluster (Peyer's patch)
(58932, 58941)
No lesions of significance
Mesenteric lymph node
Section does not include mesenteric lymph node
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Spleen
Unremarkable follicular pattern identified with typical red and white pulp micromorphology.
Moderate extramedullary hematopoiesis and Hemosiderin laden macrophages identified in the
red pulp of the spleen, a common finding in the mouse.
(58924)
No lesions of significance
Pancreas
Section shows representative exocrine tissue (serous acini) and endocrine tissue (islets of
Langerhans) with mild multifocal perivascular lymphocytic infiltrates.
(58924, 58940)
Kidney
Section shows a cortex, medulla, and papilla with uniform distribution of Glomeruli and
accompanying nephron components.
Mild multifocal perivascular lymphocytic infiltrates, and a few protein casts within the medulla
and papilla.
Section also includes renal lymph nodes with typical reactive nodal histology and mild sinus
histiocytosis.
(58935, 59373)
Adrenal glands
Section shows adrenal glands with typical cortex/medulla distribution with a few age related
lipofuscin laden cells at the cortical-medullary junction and mild subcapsular spindle cell
hyperplasia, a common background lesion.
(58935, 59373)
Salivary glands and Regional lymph nodes
Mild multifocal perivascular lymphocytic infiltrates within the submandibular gland and
unremarkable sublingual and parotid glands.
The regional lymph nodes displayed mild follicular hyperplasia with germinal centre formation,
indicating a reactive state.
(58926)
Thyroids
Normal lateral lobes of the thyroid gland with typical colloid secreting follicles lined by cuboidal
epithelium.
(58931)
No lesions of significance
Trachea/Lungs
Section shows lung micromorphology demonstrating parenchyma/alveoli, bronchioles, blood
vessels and parabronchial lymph node with mild focal perivascular lymphocytic infiltrates.
Trachea with unremarkable mucosal epithelial lining and hyaline cartilage.
Oesophagus with typical features including stratified squamous epithelium.
(58931)
Thymus
Section shows typical medulla/cortex distribution and micromorphology.
(58930)
No lesions of significance
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Heart/chambers/vessels/valves
Section shows cardiac muscle, chambers, valves and vessels of the heart.
The cardiac muscle fibres demonstrated typical features including central nuclei, branching fibres
and striations.
Query: eosinophilic islands within the myocardium judged to be degenerating myocytes.
(58938)
Comments:
Pathology to comment
Skin
Typical dermal appendages and distribution. Unremarkable thin layer of striated muscle
(panniculus carnosus).
(58927)
No lesions of significance
Tail
Section shows typical tail components including keratinized squamous epithelium, dense regular
connective tissue, tendons, caudal vertebra, bone marrow, intervertebral disc, skeletal muscle,
nerves and blood vessels.
(58922)
No lesions of significance
Eyes/Harderian glands
Section shows eyes with unremarkable retina, cornea, iris, ciliary body, lens, sclera and choroid.
Typical branched tubuloalveolar formation of the Harderian gland and a mild focal lymphocytic
inflammtory infiltrates.
Section also includes portion of unremarkable optic nerve and extraocular muscles.
(58939)
Brain
Sections were prepared from the standard levels of the brain:
Level I forebrain: including cortex, corpus callosum, caudate putamen and lateral ventricles
(Bregma 0.74mm)
Level II midbrain: including the hippocampus, thalamus, hypothalamus and lateral and third
ventricles (Bregma -0.82mm)
Level III hindbrain: includes the cerebellum, pons and fourth ventricle (Bregma -5.80mm)
Sections of brain stained with Haematoxylin and Eosin, Luxol Fast Blue appear symmetrical with
no ventricular dilation observed, unremarkable meninges and typical lamination.
The cerebellum appears symmetrical with typical architecture and Purkinje cells.
There was no evidence of neuronal loss and the myelination appeared normal.
(58933, 58942)
No lesions of significance
Comments:
Neuropatholoy to comment
Spinal cord
Representative thoracic and lumbar region of spinal cord, vertebral bone, striated muscle,
peripheral nerves and bone marrow.
(58933)
No lesions of significance
Comments:
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Neuropatholoy to comment
(Hind leg) Long bone/Bone marrow/Synovial joint/Skeletal muscle
Section shows unremarkable long bone, striated muscle, synovial joint and bone marrow
including conspicuous megakaryoblasts. The skeletal muscle shows consistent fiber size with
peripheral nuclei.
(58937)
No lesions of significance
Head
Multiple levels through the head demonstrate dermal appendages, nasal cavity, oral cavity, teeth
and tongue including muscle bundles. Sections also show unremarkable pituitary gland including
pars intermedia and pars distalis as well and the trigeminal nerve/ganglia (58943).
The outer and middle regions of the ear are discernible. The tympanic membrane is intact and
the ossicles are unremarkable and include the stapedial annular ligaments (58944, 58945).
Stria vascularis of the inner ear is discernible (58944, 58945).
Examples of otolith organs can be seen with typical features such as the hair cells and mineral
otoliths. The ampulla including the crista ridge with hair cells is discernible (58944, 58945).
No lesions of significance
(58943, 58945)
Comment / Plan
Case APN16/042 will be referred to Professor Rolfe Howlett R&A Pathology Services NSW and
Professor Catriona McLean, Anatomical Pathology, Alfred Hospital Melbourne for comment.
Aira Nuguid
1st February, 2017
Revised by AN
8th February, 2017
Supplementary Pathology Report
ENU28 11 G7#338 (control)
ENU28 11 G7#340 (control)
ENU28 11 G7#345 (control)
ENU28 11 G7#355
Ovary/ Fallopian tubes/Uterus  / Vagina
The ovaries  contain varying stages of follicles, several corpora lutea and mild to moderate ceroid
–lipofuscin laden cells. Unremarkable oviduct micromorphology. No other changes of
significance.
Mild cystic hyperplasia of the uterus. The uterus and vagina display features that place the
mouse in metoestrus. The lining of the stratified squamous epithelium has lost the keratinisation
layer and inflammatory cells occur along the lumenal surface of the vaginal wall.
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Urinary Bladder
The bladder wall is distended with the urothelium easily discernible. No lesions of significance.
There is no inflammatory change of significance
Liver /Gall Bladder
A solitary island of mixed mononuclear inflammatory cells that involved two hepatic acini.
However as this is solitary and not active, the inflammatory lesion is not significant.
Oesophagus
The sections from  the mediastinal region does not reveal any lesion of significance.
Kidneys
Sections contain both kidneys displaying cortex , medullary rays, medulla and the pelvis.
Even spread of glomeruli through the renal parenchyma. Protein casts were occasionally
observed some appeared to extend into the terminating microcysts particularly in the medulla.
Accumulation of mainly lymphocytes was around the peripelvic tissue. The accumulation of
mononuclear inflammatory cells peri-pelvically often seems to occur as the mice age.
No lesions of significance
Adrenal glands
No lesions of significance with a few ceroid-lipofuscin containing cells  at the cortico-medullary
junction
Thyroid glands
Lateral lobe of the thyroid with colloid secreting follicles lined by cuboidal epithelium
No lesions of significance
Salivary glands and associated Lymph nodes
A mild focal area of perivascular/periductal chronic inflammation. Cells were mononuclear and
mainly lymphocytes; the inflammation is not active.
The lymph nodes display a mild follicular hyperplasia and mild sinus histiocytosis.
These features within the node are within the range of an expected reactive state of the nodes.
Lungs/ Trachea /Bronchi
A large island of small mainly reactive lymphocytes occurs in a parabronchial location;
this might represent part of the parabronchial lymph node particularly as this area has several
readily distinguished small blood vessels as though this area has an established vascular supply
vascular . This lymphocytic dominated area does not represent an active focus of inflammation.
Minimal significance especially as the mouse is older than 1 year.
Heart / major vessels / valves
Sections reveal normal right and left ventricles. The aortic valves and the atria-ventricular valves
were present. The valves had varying degrees of valvular myxomatous thickening in different
sites/locations
As many strains of mice age this is not an uncommon finding. If the thickening is at the valvular
edge then this can and does lead to a cardiac incompetence.
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ENU28 11 G7#359
Ovary/ Fallopian tubes/Uterus
Sections reveal follicles at different development  stages , several corpora Lutea and interstitially
there were macrophages filled with ceroid-lipofuscin.
Unremarkable oviducts (Fallopian tubes) although the lining epithelium is patchily vacuolated
Moderate cystic endometrial hyperplasia of the uterus.(These changes seem age related to a
major extent).
The micromorphology of the uterine wall particularly the inflammatory cells(neutrophils and
lymphocytes) suggests that this female mouse is probably in one of the phases of oestrus.
Urinary Bladder
The features of the urinary bladder wall and the urethra had no lesions of significance
Liver /Gall Bladder
Sections display features of liver and its gall bladder. The microscopic pathology  seemed to be
without lesions of significance.  However, there were scatterings and large nests (over the size of
an acinus) of mononuclear inflammatory cells (mainly lymphocytes with a few macrophages)
through the hepatic parenchyma.
These changes observed are no longer active or of significance. However the multiplicity of the
inflammatory cellular clusters are indicative of  previous inflammatory responses either singly
(additional) or multiple at a single time point.
Oesophagus
Mediastinal sections display normal oesophagus in the thorax.
Kidneys
Sections display a normal microscopic pattern of the cortex, medulla and pelvis.
The renal parenchyma had less that 5 mononuclear inflammatory cellular nests of varying size
some were located peri-pelvically while others near to the cortico-medullary junction.
These cellular aggregates did not display features of activity and were judged not to be of
significance.
Proteinaceous casts were occasionally observed.
Adrenal glands
The adrenal gland showed subcapsular spindle cell hyperplasia that had expanded vertically and
horizontally. This feature has been attributed to hormonal alteration and is observed more
frequently with aging mice.(ref: “Pathology of the Mouse” edited by Robert R Maronpot.
Thyroid glands
No lesions of significance in the lateral lobe of the thyroid gland. A small parathyroid gland
nestled in the thyroid tissue.
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Salivary glands and associated Lymph nodes
Present in the sections were parotid, sublingual and submandibular salivary glands.
In one large lobe of the parotid gland there was a diffuse acute on chronic sialadenitis with an
early regeneration. The most likely cause would be bacteria.
Additionally, there was a basophilic  hypertrophic focus consisting of a foci of enlarged acinar
glands. Such lesions have only been encountered in the parotid gland.
The regional lymph nodes displayed features consistent with a status of immuno-reactivity.
Lungs/ Trachea /Bronchi
The left lung is without any lesion of significance. However in the right lung there were multiple
small nodules of mononuclear inflammatory cells most scattered in the stroma tissue of this
lung.
The regional para-tracheal   lymph node displays minor changes but on balance of little
significance at the moment.
Microscopic foci and individual alveolar macrophages contain within their cytoplasm eosinophilic
bodies/crystals.
Thymus
Medulla and cortex distribution as described within the thymus.
There is a thymic cyst which appeared as thought it may have arisen from epithelial hyperplastic
elements.
Cysts are a common finding in the involuted thymus of aged mice. Thymic cysts were reported in
control mice up to four to five percent. “Pathology of the mouse” edited by Robert R Maronpot.
Heart / major vessels / valves
Sections reveal normal right and left ventricles. The aortic valves and the atria-ventricular valves
were present. The valves had varying degrees of valvular myxomatous thickening in different
sites/locations
As many strains of mice age this is not an uncommon finding. If the thickening is at the valvular
edge then this can and does lead to a cardiac incompetence.
ENU28 11 G7#360
Ovary/ Fallopian tubes & Uterus  / Vagina
Both ovaries were sectioned and revealed follicles, corpora lutea and some interstitial cells
containing ceroid-lipofuscin. Serosa appeared irregular in areas and possibly cystic probably
nothing more than fixation artefact. The oviducts were lined by folded epithelial lining. Some of
lining epithelial cells were vacuolated.
Moderate cystic endometrial hyperplasia has disturbed somewhat the microanatomy of these
tissues.
The micromorphology of the epithelium particularly of the vagina displays that the stratified
squamous epithelium is being thinned actively by clusters of mainly mononuclear inflammatory
cells. Such a pattern is consistent with the animal being in the oestrus cycle e.g. phase
metoestrus
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Urinary Bladder
Normal epithelial lining and detrusor muscle
Heart
sections reveal a left and right ventricle and portions of the left and right atria.
A portion of the atria  ventricular valve and one aortic valve have a noticeable thickening. Hence
depending upon where the thickening is will determine whether the lesion has an effect of the
cardiac output.
Summary
Please refer to above comments
Professor Rolfe Howlett
R&A Pathology Services, NSW
16th February, 2017
Supplementary Neuropathology Report
ENU28 11 G7#338 (control)
H&E and LFB stained brain sections were examined.
Representative H&E stained sections of spinal cord were examined.
Slides were used as histological controls.
ENU28 11 G7#340 (control)
H&E and LFB stained brain sections were examined.
Representative H&E stained sections of spinal cord were examined.
Slides were used as histological controls.
ENU28 11 G7#345 (control)
H&E and LFB stained brain sections were examined.
Representative H&E stained sections of spinal cord were examined.
Slides were used as histological controls.
ENU28 11 G7#355
H&E and LFB stained brain sections were examined.
Representative H&E stained sections of spinal cord were examined.
Sections of brain and spinal cord show no significant neuropathology.
ENU28 11 G7#359
H&E and LFB stained brain sections were examined.
Representative H&E stained sections of spinal cord were examined.
Sections of brain and spinal cord show no significant neuropathology.
ENU28 11 G7#360
H&E and LFB stained brain sections were examined.
Representative H&E stained sections of spinal cord were examined.
Sections of brain and spinal cord show no significant neuropathology.
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Summary
Sections of brain and spinal cord show no significant neuropathology.
Professor Catriona A McLean
BSc, MBBS, FRCPA, MD, FFSc (RCPA)
Head, Dept of Anatomical Pathology, Alfred Health
Professor, Central Clinical School, Monash University
Professor, The Florey Institute of Neuroscience and Mental Health
Head, Victorian Neuromuscular Laboratory Services, Alfred Health
Director, Victorian Brain Bank at The Florey
3rd February, 2017
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The Australian Phenomics Network advises all research groups that images or results obtained
through the services offered by the APN are to be acknowledged in resultant publications.
Example acknowledgement: "This study utilised the Australian Phenomics Network Histopathology
and Organ Pathology Service, University of Melbourne."
Authorised by Tina Cardamone, APN Histopathology and Organ Pathology Node manager.
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